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The myometrium is a myogenic organ which generates regular spontaneous contractions by its 
own mechanisms without any input from the hormonal or nervous systems (Wray 1993). The 
contraction of the myometrium also exhibits phasic properties accompanied with variations in 
the frequency, amplitude and duration of contraction. All of these properties enable the 
myometrium to perform its physiological function adequately and efficiently. These properties 
are also very often examined individually so as to provide a more holistic insight into the action 
and activity of the myometrium. Uterine contractions (or myometrium contractions) are activated 
on increases in intracellular calcium concentrations ([Ca2+]
i
), which are initiated and regulated by 
action potentials in the myometrium (Burdyga, Wray & Noble 2007). The myometrium (uterine 
smooth muscles) acts to prepare the uterus for the processes of maintaining and expelling the 
foetus (Wray 2007). For instance, the myometrium undergoes significant changes in the non-
pregnant uterus, which allows for the successful implantation of the fertilised embryo (Wray 
2007). In the non-pregnant uterus, the myometrium is also responsible for the contractions that 
occur during menstruation (primates) or oestrous (mammals), which potentiates the cramping 
observed often referred to as dysmenorrhoea (Togashi 2007). In this state, the myometrium is 
involved in a uterine peristaltic action that supports and contributes to the endometrial sloughing 
that occurs during menstruation (Bulletti et al. 2000). Changes in female steroid hormones 
released during this time also act to regulate the sequence of myometrial activity (Wray & Noble 
2008). For purposes of this study, it is important to emphasise that the pattern of contractile 
activity in the non-pregnant uterus is similar to uterine contraction in the pregnant uterus as well 
(Lyons et al. 1991). Contractions occurring in antegrade manner and propagating from the fundus 
towards the cervical end of the uterus are necessary for emptying or discharge of uterine content, 
Background: The plant Dryopteris filix-mas has been used traditionally for its uterine-stimulant 
effects.
Aim: The current study is therefore aimed at investigating and determining the effect of the 
leaves of D. filix-mas on uterine contractility in vitro.
Setting: Fresh leaves of D. filix-mas were collected from a river bank in the south-western part 
of Nigeria.
Methods: The leaves of D. filix-mas were cleaned, dried and extracted in methanol. The extract 
(0.07 µg/mL–21.0 µg/mL) was tested on the isolated mouse uteri in order to determine activity 
on spontaneous-induced uterine contractions. Subsequently the extract (0.005 mg/mL and 
0.05 mg/mL) was tested on oxytocin-induced contraction (0.00017 ng/mL–4.98 ng/mL) in 
calcium-containing media, submaximal oxytocin-induced contraction (0.116 ng/mL) in 
calcium-free media and in the presence of high KCl-induced uterine contractions (80 mM). The 
extract was also subjected to mass spectrometric determination of secondary metabolites.
Results: The plant extract inhibited spontaneous-induced contractions with IC
50
 amplitude = 
658.41 ng/mL ± 0.11 ng/mL and IC
50
 frequency = 175.32 ng/mL ± 0.53 ng/mL. The plant 
extract inhibited oxytocin-induced and high KCl-induced uterine contractions (p < 0.01 at 0.5 
mg/mL). The plant extract had no effect on oxytocin-induced contractions under calcium-free 
conditions. Secondary metabolites belonging to classes of fatty acids, alkaloids, saponin 
glycosides, amino acids, limonoids, terpenes and porphyrins were identified.
Conclusion: The current study reports an inhibitory effect of the plant on uterine contractility 
in this study, suggesting possible application as a tocolytic or as a contraceptive, as most 
contraceptive plants have shown uterine-relaxing effect.
ƌǇŽƉƚĞƌŝƐĮůŝǆ ?ŵĂƐ (Dryopteridaceae) leaves inhibit 
ŵŽƵƐĞƵƚĞƌŝŶĞĂĐƟǀŝƚǇ
Copyright:  ? ? ? ? ? ?dŚĞƵƚŚŽƌƐ ?>ŝĐĞŶƐĞĞ PK^/^ ?dŚŝƐǁŽƌŬŝƐůŝĐĞŶƐĞĚƵŶĚĞƌƚŚĞƌĞĂƟǀĞŽŵŵŽŶƐƩƌŝďƵƟŽŶ>ŝĐĞŶƐĞ ?
WĂŐĞ ?ŽĨ ? ? KƌŝŐŝŶĂůZĞƐĞĂƌĐŚ
ŚƩƉ P ? ?ǁǁǁ ?ũŽŵƉĞĚ ?ĐŽ ?ǌĂ KƉĞŶĐĐĞƐƐ
which may be the menstrual blood (non-pregnant uterus) or 
foetus (pregnant uterus) (Lyons et al. 1991). The cervico-
fundal contractions also assist in electrolyte retention as well 
as sperm transport (Kunz & Leyendecker 2002). Retrograde 
contractions in the myometrium during pregnancy may 
contribute to the maintenance of early pregnancies within the 
uterine cavity (de Vries et al. 1990).
From the foregoing, it is clear that uterine contractility 
constitutes an important parameter of female reproductive 
health.
Maternal morbidity and mortality arising from female 
reproductive health disorders are a serious concern. Women 
in Africa bear a disproportionately large share of the global 
burden of disease and death, particularly in maternal 
morbidity and mortality. Africa as a whole accounts for more 
than half of all cases of maternal deaths worldwide, and 
African women have a 1 in 42 lifetime risk of dying during 
childbirth compared with 1 in 2900 in Europe. Understanding 
the roles of drugs or natural products in uterine contractility 
therefore will assist in providing useful information going 
forward in the improvement of female reproductive health in 
general. For many women, current therapies offer inadequate 
treatment, and this includes management of a range of health 
issues from dysmenorrhoea to complications of pregnancy 
(Marsden, Strickland & Clements 2004) and the search for 
new treatment options continues. Interests in medicines from 
natural products (plants inclusive) have soared through the 
years. Plant preparations in the forms of decoctions, 
concoctions, macerations or infusions are used to treat a wide 
range of diseases. Use of plant medicines has also been 
utilised to tackle human reproductive health issues, which as 
stated earlier remains a public health concern worldwide. 
Use of medicinal plants has therefore become a mainstay in 
several cultures, including Africa (Dugoua 2010; Fakeye, 
Adisa & Musa 2009). This therefore indicates that research 
into plants hold a strong potential in the elaboration of new 
therapies to tackle reproductive health issues. One such plant 
that has been reported to have effect on some reproductive 
concerns is the plant, Dryopteris filix-mas.
Dryopteris filix-mas is a hardy ornamental fern (Duke 2001). It 
is considered a traditional wild vegetable (Mohammed 
Abdus Satter 2016). It is commonly referred to as ‘wild fern’, 
or ‘bear’s paw’ and botanically described as Dryopteris filix-
mas (Linn.) Schott, and the family name is Dryopteridaceae 
(Nwosu 2002). The local Nigerian names are ‘Ihi’ and ‘Erinji’ 
(Nwosu 2002). It grows in a wide range of habitats such as 
open ground, but is commonly found in moist environs and 
deciduous forests. The plant grows in all parts of Europe, 
temperate Asia, North India, North and South America, the 
temperate parts of the USA and also grows in Africa 
(Uwumarongie, Enike & Bafor 2016). The plant is highly 
adaptable and can grow well in both arid and fertile soils 
(Duke 2001). It favours damp shady areas in the understory 
of woodlands but also shady places in hedge-banks and 
rocks. The plant is sometimes referred to in ancient literature 
as Worm Fern because it has been used in traditional medicine 
for the treatment of worm infections (Mohammed Abdus 
Satter et al. 2016). There is however some documented 
information on the biological or medicinal activities of D. 
filix-mas with most reports focused on ferns as a class. Some 
of the available reports are described here. The early 
physician, Theophrastus, recognised the value of the fern for 
treating tinea (ringworm) infections (Duke 2001). Male Fern 
has also sometimes been used as a tonic and vulnerary in 
China; it is used for wounds and haemorrhages, such as 
epistaxis, menorrhagia and postpartum haemorrhage (a 
reproductive complication). The plant has the potential to 
arrest embryonic development in insects (suggestive of a 
potential reproductive function) (Snehlata & Tiwari 2011). 
The plant has been reported to have uterine stimulant effects 
traditionally and has been advised to be avoided during 
breastfeeding as the plant contains anthraquinones, which 
may induce diarrhoea and colic in infants (Cock 2015). The 
plant has also been reported to increase the size of the 
male reproductive organ through mechanisms yet unknown 
(Kantemir, Akder & Tulunay 1976); however, this action may 
be suggestive of an oestrogenic or androgenic effect. The 
young coiled fronds of the plant are used in different parts of 
Nigeria as an antihelminthic, and infusion of the leaves is 
additionally used as an aphrodisiac (Nwosu 2002). The plant 
has also been reported to have potent antioxidant and 
cytotoxic activities (Sekendar Ali et al. 2012), insecticidal 
activity (Shukla & Tiwari 2011) and antimicrobial activities 
(22). The plant has been reported to contain a high 
concentration of K+ (1065.45 ± 1.13 mg/100 g) and reasonable 
concentrations of Ca2+ (279.16 ± 1.33 mg/100 g), Mg2+ (148.50 ± 
0.65 mg/100 g) and Na+ (94.44 ± 0.66 mg/100 g) (Mohammed 
Abdus Satter et al. 2016).
Based on its reported use in postpartum haemorrhage and 
uterine stimulation, this study sets out to verify this use and 
examines some parameters on possible mechanisms of 
activity. The study is therefore aimed at investigating the 
activity of the plant extract on uterine contractility, 
investigating preliminary mechanisms of activity and 
determining secondary metabolites contained in the leaf, 
which can serve as a basis for further drug discovery studies.
Materials and method
Plant material
Fresh leaves of D. filix-mas (hereafter DF) were collected 
between July and August, 2015, from the river bank of Osun 
River at Osogbo, Osun State, Nigeria. It was authenticated by 
Dr H.A. Akinnibosun from the Department of Botany, Faculty 
of Life Sciences, University of Benin, Edo State, Nigeria. A 
voucher specimen has been prepared with voucher number 
of UBN/PCG/1658 and deposited at the Department of 
Pharmacognosy, University of Benin, Nigeria.
Animals
Mature non-pregnant female albino mice weighing an 
average of 24 ± 0.66 g were obtained from the Animal House 
Department of Pharmacology and Toxicology, Faculty of 
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Pharmacy, University of Benin, Edo State, Nigeria. They 
were housed in plastic cages at an environmentally 
controlled room temperature of approximately 27 ± 5°C 
and environmentally controlled lighting conditions of 
approximately 11 h/13 h light and dark cycles. Relative 
humidity ranged from 85% to 88%. The animals were 
acclimatised to these conditions. Handling was done as 
much as possible according to standards of the Public 
Health Service policy on humane care and use of Laboratory 
Animals (Office of Laboratory Animal Welfare & NIH 2015; 
National Research Council 2010). The animals were 
maintained on standard diet of animal pellets and clean 
tap water.
Drugs and chemicals
Methanol of high analytical grade (Pharmatrends, 
Nigeria) and tween 80 (Sigma Aldrich, UK) were solvents 
used in this study. Salts for the physiological solution 
were obtained from BDH chemicals, England. Other 
drugs used in this study include oxytocin (Laborate 
Pharmaceuticals, India) and diethylstilboesterol (Sigma 
Aldrich, UK). For the mass spectrometric experiments, 
methanol (MeOH), dichloromethane (DCM), acetonitrile 
(MeCN) and formic acid were purchased (Fisher Scientific, 
Hemel Hempstead, UK). All reagents were of analytical 
grade.
WƌĞƉĂƌĂƟŽŶŽĨĞǆƚƌĂĐƚ
The plant material was air-dried for 5 days followed by 
controlled oven-drying at 40 °C after which it was reduced to 
powder form by using an electric milling machine (Christy 
Norris, England). The powdered samples were kept in 
airtight containers and stored in the refrigerator at 4 °C until 
needed. Five hundred grams (500 g) of the powdered plant 
material was macerated in 2.5 L methanol, and the extract 
obtained was concentrated under pressure by using a rotary 
evaporator maintained at 40  °C. The extract weight was 
98.65 g giving a yield of 5.07 %w/w.
ŽŶƚƌĂĐƟůŝƚǇƐƚƵĚŝĞƐ
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Twenty-four hours prior to the day of experiments, each 
mouse was administered 1.0 mg/kg diethylstilbestrol orally 
by using a feeding syringe (Bafor, Omogbai & Ozolua 2010). 
This dose and route of administration had been previously 
determined in our laboratory to effectively induce oestrous. 
Diethylstilbestrol was constituted in Tween 80 and distilled 
water (1:1). On the day of the experiment prior to the 
experiment proper, vaginal smears were obtained and 
prepared (Caligioni 2009; Cora, Kooistra & Travlos 2015). 
Briefly the smears were collected by flushing with distilled 
water by using a Pasteur pipette (0.1 mm). A smear was made 
on a clean glass slide, fixed with ethanol and stained with a 
drop of gentian violet. The smear was then viewed under a 
microscope. Once the stage of oestrous was ascertained, the 
mouse was then humanely sacrificed. Animals in pro-
oestrous and oestrous states (Figure 1) were used for the 
experiments (Bafor et al. 2014). The selected mouse was 
humanely killed by cervical dislocation and the uterine horns 
were immediately excised and immediately placed into a 
petri dish containing previously warmed and aerated 
physiological salt solution. The uterine tissues were cleaned 
of connective tissues and one horn was transected medially 
in half. Tissue lengths of approximately 1–2 mm each were 
obtained. The uterine segment was then mounted in a 
warmed 10-mL organ bath maintained at 37 °C and containing 
aerated physiological solution. The physiological salt 
solution used was of the following composition in M: NaCl 
154.00, NaHCO
3





O 2.05 (Bafor et al. 2014).
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The mounted tissues were equilibrated under resting tension 
of 4.90 mN for 30–45 min (time duration used was dependent 
on when regular contractions were obtained) (Bafor et al. 
2014; Sukwan, Wray & Kupittayanant 2014). The force and 
frequency of uterine contractions in the longitudinal muscle 
layers were measured by using a 7003E-isometric force 
a b
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transducer (Ugo Basile, Varise, Italy) connected to a 17 400 
data capsule digital recorder with an inbuilt bridge amplifier 
(Ugo Basile, Varese, Italy).
Experiment on the effect of extract on spontaneous uterine 
contraction: The direct effect of cumulative concentrations of 
the extract on uterine smooth muscle contractility was 
investigated (Bafor et al. 2014, 2017; Elvis-offiah, Iyawe & 
Bafor 2016; Sukwan, Wray & Kupittayanant 2014). 
Concentration–response relationships were obtained by 
using concentrations between 0.07 µg/mL and 21.0 µg/mL. 
The concentration used had been predetermined in our 
laboratory as concentrations covering the range of effects of 
the extract. A contact time of 3 min was allowed following 
each concentration of extract administered. After each set of 
administration, the tissues were washed three times and a 
wash-out over a minimum period of 10 min was allowed for 
the tissue to recover before the next administration.
Experiment on the effect of extract on oxytocin-induced 
uterine contraction: Conversion of oxytocin from 
international units (IU) to milligram (mg) was in accordance 
with the World Health Organization recommendation where 
10 IU = 16.6 µg/mL (World Health Organization 2010). After 
tissue equilibration, the effect of the extract on oxytocin-
induced uterine contraction was investigated. This was 
carried out by first performing a concentration–response to 
oxytocin (0.00017 ng/mL–4.98 ng/mL) in the absence of the 
extract. This was then repeated in the presence of cumulative 
sub-maximum concentrations of the extract at 0.005 and 0.05 
mg/mL at 5 min each.
Experiment on the effect on high KCl-induced uterine 
contractility: The effect of the extract was determined in the 
presence of high KCl (80 mM). KCl (80 mM) was added to the 
bath containing the uterine tissues and left in contact for 5 
min and without washing cumulative concentrations of the 
extract (0.0005 mg/mL–0.5 mg/mL) were determined.
Experiment on the effect of the extract in Ca2+-free medium: 
After tissue equilibration for 30 min, the physiological salt 
solution was changed to one without calcium and containing 
0.1 mM of ethylenediaminetetraacetic acid. The tissue was 
then equilibrated in the Ca2+-free solution for a further 15 
min. After equilibration, oxytocin (0.116 ng/mL) was added 
and a contact time of 5 min was allowed. Without flushing, 
cumulative concentrations of the extract (0.07 µg/mL–210.00 





Samples and medium control samples were prepared at a 
concentration of 1 mg/mL in 80:20 MeOH:DCM. A solvent 
blank was also included. Liquid chromatography-high 
resolution Fourier Transform mass spectrometry (LC-
HRFTMS) analysis was performed on a Dionex UltiMate-3000 
(DIONEX, Sunnyvale, CA, USA) coupled to a Thermo 
Scientific Exactive Orbitrap system (Thermo Fisher Scientific 
[Bremen], GmbH, Bremen, Germany). The mass accuracy 
was set to less than 3.0 ppm. The instrument was externally 
calibrated according to the manufacturer’s instructions 
before the run. The column used was an ACE 5 C18 75 mm × 
3.0 mm column from Hichrom Ltd., Reading, UK. Ten micro-
litres of the sample was injected from the vial, and compounds 
were eluted with a flow rate of 300 µL/min by using water 
(A) and acetonitrile (B), both of which contained 0.1% formic 
acid, by a gradient starting with 10% B and increasing to 
100% B in 30 min. The mobile phase was maintained at 100% 
B for 5 min after which the column was equilibrated with 
10% B. The UV absorption wavelength was set at 254 nm, the 
sample tray temperature was maintained at 4 °C and the 
column was maintained at 20 °C. The files were sliced into 
positive and negative data sets by using ProteoWizard 
(Kessner et al. 2008) prior to data mining by using MZmine 
2.10 (Pluskal et al. 2010). Peak detection was accomplished by 
using the centroid mass detector and a noise level of 1000. 
The chromatogram builder generated peak lists from the 
mass lists obtained from the previous step. The minimum 
time span was 0.2 min, minimum height was 10 000, and the 
m/z tolerance was set to 0.0001 m/z or 5 ppm. Chromatogram 
deconvolution was accomplished by using the local minimum 
search algorithm with the following parameters: threshold 
(90%), search minimum in retention time (RT) range (0.4 
min), minimum relative height (5%), minimum absolute 
height (10 000), minimum ratio of peak top/edge (Burdyga et 
al. 2007) and peak duration range (0.2–5.0 min). The peak 
lists were de-isotoped by using the isotopic peaks grouper 
with an m/z tolerance of 0.001 m/z or 5 ppm, RT tolerance of 
0.1 min (absolute) and maximum charge of 2. The 
representative isotope was the most intense. The peak lists 
were then merged by using the Alignment function. The 
weight for m/z and for RT was 20, and the RT tolerance was 
5%. The aligned peak lists were gap-filled by using the Peak 
Finder, with an intensity tolerance of 1% and RT tolerance of 
0.5 min (absolute). Adducts were identified, together with 
other complexes that may have formed during ionisation. 
The chemical formulae of each peak were predicted by using 
the formula prediction tool developed by MZmine. Hits from 
the database were accessed by using ChemBioFinder version 
13 (PerkinElmer Informatics, Cambridge, UK).
Data analysis
The mean frequency and amplitude were calculated from 
contractions occurring at the last 3 min of the phasic 
contractions by using the GraphPad Prism (version 7.03; 
GraphPad software Inc., San Diego, CA, USA). Results were 
obtained as percentages of control applications (control = 100%). 
In some experiments, changes in force (amplitude) were 
expressed with respect to basal resting force level (100% 
amplitude). All data shown were expressed as mean ± 
standard error of mean and n represents the number of 
samples each from different animal, and in this study n = 5 
animals. Significance was evaluated by using appropriate 
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t-tests, and where necessary, one-way analysis of variance 
with Dunnett’s post hoc and p values  0.05 was taken to 
represent minimum significance in all cases.
In datasets with sufficient data points, mean log 
concentration–response curves were analysed by fitting data 
to a four-parameter logistic equation, by using the following 
equation values (Y = Bottom)/(1 + 10^[(LogIC50-
X)×HillSlope)], where Y = response which starts at the bottom 
and goes to the top in sigmoid shape, X = logarithm of 
concentration and IC
50
 is the concentration that produces half 
the maximal responses.
ƚŚŝĐĂůĐŽŶƐŝĚĞƌĂƟŽŶƐ
All animal experiments were performed according to 
approved guidelines for Humane Care and Use of Laboratory 
Animals and after prior approval of the institutional animal 
ethics committee, which is also stated within the article.
Ethical approval was obtained from the Ethical Committee, 
Faculty of Pharmacy, University of Benin, and an approval 
number was provided, EC/FP/016/04.
Results
sĂŐŝŶĂůĐǇƚŽůŽŐǇŽĨƚŚĞĞǆƉĞƌŝŵĞŶƚĂůĂŶŝŵĂůƐ
Representative exfoliative vaginal cytology for the stage of 
the oestrous cycle of animals utilised for this study is shown 
in Figure 1. The relative prevalence of the cell type was used 
to ascertain the oestrous state for each recipient mouse. 
Typically animals in the oestrous and pro-oestrous stages 
were used for this study.
īĞĐƚŽĨĞǆƚƌĂĐƚŽŶƐƉŽŶƚĂŶĞŽƵƐƵƚĞƌŝŶĞ
ĐŽŶƚƌĂĐƟŽŶƐ
Rhythmic contractions occurred in about 90% of uterine 
tissue preparations containing both longitudinal and circular 
smooth muscle in this study, which were subsequently 
utilised for studies on spontaneous uterine contractility. 
Cumulative concentration–response experiments were 
performed to determine the effects of the extracts on the force 
and frequency of spontaneous uterine contractions. Response 
curves were determined for DF (n = 5). DF extract was 
observed to induce mild inhibitions in the amplitude and 
frequency of spontaneous contractions at concentrations 
used in this study (Figure 2). Inhibitions were more 
pronounced at higher concentrations particularly at 210.00 
µg/mL (Figure 2). Concentration producing 50% inhibition 
of responses (IC
50
) were extrapolated to give IC
50
 amplitude = 
658.41 ng/mL ± 0.11 ng/mL and IC
50
 frequency = 175.32 ng/
mL ± 0.53 ng/mL.
īĞĐƚŽĨĞǆƚƌĂĐƚŽŶŽǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚƵƚĞƌŝŶĞ
ĐŽŶƚƌĂĐƟŽŶƐ
Experiments were performed to characterise the activities of 
DF on oxytocin-induced uterine contractions. The DF extract 
was observed to decrease the response of oxytocin-induced 
uterine contraction (Figure 3). The effect on the amplitude 
(force) of oxytocin was more pronounced than the effect seen 
on the frequency, which had more variability (Figure 3). DF 
was observed to decrease both the amplitude and frequency 
of oxytocin-induced contraction in a concentration-
dependent manner (Figure 4). A rightward shift was observed 
in the response to oxytocin at the concentrations of DF used 
in this study (Figure 4). DF effectively depressed the 
oxytocin’s action on uterine contraction at both concentrations 
utilised in this study.
īĞĐƚŽĨ ?Įůŝǆ ?ŵĂƐ on high KCl-induced (80 
ŵD ?ƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶƐ
Characterisation of the actions of DF to high K+ solution 
was performed. The possibility of interaction of DF with 
extracellular calcium channels involved in high K+ 
depolarisation of smooth muscles (Triggle 1987) was 
investigated. As shown in Figure 5, high KCl solution 
produced a rapid increase in force, which was immediately 
preceded by a decline and rapidly oscillating production of 
force (Crichton et al. 1993). Application of DF extract 
altered this activity at the highest concentration used for 
this protocol (Figure 5). The DF extract was observed to 
decrease significantly (p < 0.01) the contractile force 
(amplitude) of KCl-induced contractions at 0.5 mg/mL 
used (Figure 5).
īĞĐƚŽĨ ?Įůŝǆ ?ŵĂƐ in Ca2+-free medium
Further experiments were designed to investigate 
whether DF extract could inhibit internal Ca mobilisation 
from the sarcoplasmic reticulum (Arrowsmith & Wray 
2014; Wray & Arrowsmith 2010). To do so, internal Ca 
mobilisation was blocked by utilisation of a Ca-free 
medium. In the absence of Ca2+, DF (0.07 µg/mL–210.00 
µg/mL) was observed to have no significant effect on 
oxytocin-induced contractions (Figure 6). However, mild 
inhibitions were observed at the highest concentration of 
DF utilised (Figure 6).
/ĚĞŶƟĮĞĚƐĞĐŽŶĚĂƌǇŵĞƚĂďŽůŝƚĞƐŝŶ ?Įůŝǆ ?ŵĂƐ
LC-HRFTMS was utilised to identify putative metabolites 
involved in the activity of DF on uterine contractility, which 
can be investigated further. The LC-HRFTMS results and 
database search (by using Dictionary of Natural Products) 
enabled the detection of 18 significant compounds (Tables 1 
and 2), 10 of which were identified (Table 1) and 8 were 
unknown (Table 2). The identified compounds included, 
4-acetyl-2,4-octadienoic acid (1), aurantiamide (2), 
trillenogenin (3), asperphenamate (4), 10,15-cyclo-11,14-
dihydroxy-1,2-dinor-6-phyten-3-one (5), detigloyl-6-deoxy-
2-hydroxyswietenine (6), 24(23ĺ22)-abeo-16,23-epoxy-3,23-
dihydroxycholesta-5,24-dien-18-al (7), chlorocruoroporphyrin 
(8), 17-hydroxyingenol (9) and phylloerythrin (10) (Figure 7). 
The identified compounds were observed to belong to a 
diverse range of phytochemical classes including fatty acids, 
phenols, terpenoids and tetrapyrroles.
WĂŐĞ ?ŽĨ ? ? KƌŝŐŝŶĂůZĞƐĞĂƌĐŚ
ŚƩƉ P ? ?ǁǁǁ ?ũŽŵƉĞĚ ?ĐŽ ?ǌĂ KƉĞŶĐĐĞƐƐ
Discussion
The myometrium (smooth muscle layer of the uterus) is 
active throughout life and not restricted to periods of labour 
and delivery. Uterine contraction therefore occurs throughout 
the menstrual cycle in non-pregnant states as well as the 
pregnant states, in a complex and dynamic physiological 
phenomenon (Aguilar & Mitchell 2010). Some of the 
unwanted but frequently observed results of myometrial 
dysfunction are contractions that are not timed leading to 
abortions or preterm delivery, or stronger than necessary 
contractions causing foetal distress, hypoxia and even death 
of the foetus (Aguilar & Mitchell 2010; Wray 2007). The non-
pregnant myometrium exhibits contractions at different 
phases of the menstrual cycle; these include rhythmic, ‘wave-
like’ contractions, oftentimes referred to as uterine peristalsis 
or spontaneous contractions, and the ‘focal and sporadic 
bulging of the myometrium’ (Togashi 2007; Togashi et al. 
1993), leading to sustained contractions. These contractions 
are important in endometrial sloughing (Wray & Noble 2008) 
and assist in sperm passage (Pehlivano÷lu, Bayrak & Do÷an 
2013). In late-term pregnancy, the myometrium contracts via 
similar mechanisms as occurs in the non-pregnant uterus 
with differences in morphology and concentrations of 
circulating hormones to systematically ensure successful 
expulsion of the foetus in the absence of any abnormalities 
(Pehlivano÷lu et al. 2013). Therefore, regardless of the 
presence or absence of pregnancy, uterine contractions are 
dependent on the contractile activity of the cellular elements, 
the uterine myocytes. The uterine myocytes are cells of the 
myometrium, which often exhibits a phasic contractile 
pattern such that the resting tone of the uterus is maintained. 
This resting tone is often superimposed by separate 
intermittent set of contractions with varying frequency, 
amplitude and duration. It is predominantly regulated by 
intracellular calcium concentra tion ([Ca2+]
i
) (Aguilar & 
Mitchell 2010; Wray 2007). DF was found in this study to 
inhibit this spontaneous intrinsic uterine contraction 
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FIGURE 2:īĞĐƚŽĨ ?Įůŝǆ ?ŵĂƐ ?& ZŽŶƐƉŽŶƚĂŶĞŽƵƐƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶ ? ?Ă ZKƌŝŐŝŶĂůƌĞĐŽƌĚŝŶŐƐŚŽǁŝŶŐƚŚĞĞīĞĐƚŽĨ&ŽŶƐƉŽŶƚĂŶĞŽƵƐĐŽŶƚƌĂĐƟůŝƚǇŽĨƚŚĞŝƐŽůĂƚĞĚŵŽƵƐĞ
ƵƚĞƌƵƐ ? ?ď ZŽŶĐĞŶƚƌĂƟŽŶ WƌĞƐƉŽŶƐĞĐƵƌǀĞƐƐŚŽǁŝŶŐƚŚĞĞī ĐƚŽĨ&ŽŶƚŚĞĂŵƉůŝƚƵĚĞŽĨƐƉŽŶƚĂŶĞŽƵƐƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶƐ ? ?Đ ZŽŶĐĞŶƚƌĂƟŽŶ WƌĞƐƉŽŶƐĞĐƵƌǀĞƐƐŚŽǁŝŶŐƚŚĞ
ĞīĞĐƚŽĨ&ŽŶƚŚĞĨƌĞƋƵĞŶĐǇŽĨƐƉŽŶƚĂŶĞŽƵƐƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶƐ ?ĐŽŶĐĞŶƚƌĂƟŽŶ ?ĚĞƉĞŶĚĞŶƚŝŶŚŝďŝƟŽŶĨŽƌďŽƚŚƚŚĞĂŵƉůŝƚƵĚĞĂŶĚĨƌĞƋƵĞŶĐǇǁĂƐŽďƐĞƌǀĞĚ ?n A䄀  ?ĂŶŝŵĂůƐ ?
WĂŐĞ ?ŽĨ ? ? KƌŝŐŝŶĂůZĞƐĞĂƌĐŚ
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FIGURE 4:ŽŶĐĞŶƚƌĂƟŽŶ WƌĞƐƉŽŶƐĞĐƵƌǀĞƐŽĨŽǆǇƚŽĐŝŶ ? ? ? ? ? ? ?ŶŐ ?ŵ> W  ? ? ?ŶŐ ?ŵ> ZŝŶƚŚĞƉƌĞƐĞŶĐĞŽĨ ? Įůŝǆ ?ŵĂƐ ?& Z ? ?Ă ZīĞĐƚŽĨ& ? ? ? ? ? ?ŵŐ ?ŵ>ĂŶĚ ? ? ? ?ŵŐ ?ŵ> ZŽŶ
ƚŚĞĂŵƉůŝƚƵĚĞŽĨŽǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚĐŽŶƚƌĂĐƟŽŶƐ ? ?ď ZīĞĐƚŽĨ& ? ? ? ? ? ?ŵŐ ?ŵ>ĂŶĚ ? ? ? ?ŵŐ ?ŵ> ZŽŶŽǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚĐŽŶƚƌĂĐƟŽŶƐ ?ĐŽŶĐĞŶƚƌĂƟŽŶ ?ĚĞƉĞŶĚĞŶƚŝŶŚŝďŝƟŽŶ
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FIGURE 3:KƌŝŐŝŶĂůƌĞĐŽƌĚŝŶŐƐƐŚŽǁŝŶŐƚŚĞĞīĞĐƚŽĨ ?Įůŝǆ ?ŵĂƐ ?& ZŽŶŽǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶ ? ?Ă ZKƌŝŐŝŶĂůƌĞĐŽƌĚŝŶŐŽǆǇƚŽĐŝŶ ? ? ? ? ? ? ?ŶŐ ?ŵ> W ? ? ? ?ŶŐ ?ŵ> Z
ŽŶƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟůŝƚǇŽĨƚŚĞŝƐŽůĂƚĞĚŵŽƵƐĞƵƚĞƌƵƐ ? ?ď ZKƌŝŐŝŶĂůƌĞĐŽƌĚŝŶŐƐŚŽǁŝŶŐƚŚĞĞīĞĐƚŽĨŽǆǇƚŽĐŝŶ ? ? ? ? ? ? ?ŶŐ ?ŵ> W ? ? ? ?ŶŐ ?ŵ> ZŝŶƚŚĞƉƌĞƐĞŶĐĞŽĨ& ? ? ? ? ? ?ŵŐ 











































FIGURE 5:īĞĐƚŽĨ ?Įůŝǆ ?ŵĂƐ ?& ZŽŶŚŝŐŚ<ů ?ŝŶĚƵĐĞĚ ? ? ?ŵD ZƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶ ? ?Ă ZKƌŝŐŝŶĂůƌĞĐŽƌĚŝŶŐŽĨ&ŽŶŚŝŐŚ<ů ?ŝŶĚƵĐĞĚƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶ ? ? ?ŵD Z ? ?ď Z
ĂƌŐƌĂƉŚƐƐŚŽǁŝŶŐƚŚĞĞīĞĐƚŽĨ& ? ? ? ? ? ? ? W ? ? ?ŵŐ ?ŵ> ZŽŶ<ů ?ŝŶĚƵĐĞĚĐŽŶƚƌĂĐƟŽŶ ?ƐŝŐŶŝĮĐĂŶƚĚĞƉƌĞƐƐŝŽŶ ?pAM ? ? ? ? ZǁĂƐŽďƐĞƌǀĞĚĂƚƚŚĞŚŝŐŚĞƐƚĐŽŶĐĞŶƚƌĂƟŽŶŽĨ&
ƵƐĞĚŝŶƚŚŝƐƐƚƵĚǇŽĨ**p AM ? ? ? ? ?n A䄀  ?ĂŶŝŵĂůƐ ?
WĂŐĞ ?ŽĨ ? ? KƌŝŐŝŶĂůZĞƐĞĂƌĐŚ
ŚƩƉ P ? ?ǁǁǁ ?ũŽŵƉĞĚ ?ĐŽ ?ǌĂ KƉĞŶĐĐĞƐƐ
myocyte activity via inhibition of [Ca2+]
i
. An increase in [Ca2+]
i
 
is reported to activate a calcium ion (Ca2+)-dependent 
cytosolic protein, calmodulin (CalM), which is capable of 
binding up to four Ca2+ ions (Johnson et al. 1996). Formation 
of the Ca2+-CalM complex activates the enzyme myosin light 
chain kinase (MLCK) resulting in an increase in the 
phosphorylation of myosin regulatory light chain-20 
(MLC20) and subsequent cross-bridge cycling (Shojo & 
Kaneko 2001). MLC20 phosphorylation by MLCK is the 
principal determinant of the amplitude and duration of 
contraction (Butler et al. 2013; McConnell & Wadzinski 2009). 
MLCK contains several phosphorylation target sites for 
protein kinase A, protein kinase C (PKC) and other kinases 
(Aguilar & Mitchell 2010; Wray et al. 2001) which may 
contribute to its activity. It may therefore seem that the 
inhibition of the amplitude of myometrial contraction 
markedly observed in this study may be attributed to the 
prevention of MLC20 phosphorylation by DF. Activation of 
MLCK by CalM translocation of activated MLCK towards 
the contractile apparatus may be the rate-limiting step of 
contraction (Wray et al. 2003) determining the contraction 
frequency of the myometrium. It would also seem that with 
the effect of DF being somewhat more pronounced on the 
amplitude than the frequency of spontaneous contractions, 
DF may exert less activity on MLCK activation and possibly 
a greater effect on prevention of MLC20 phosphorylation.
This study additionally reports the inhibition of oxytocin-
induced uterine contraction by DF. Oxytocin is known 
largely for its stimulatory actions on myometrial contraction 
(Pehlivano÷lu et al. 2013) where it is widely used to reinforce 
labour contractions. Oxytocin stimulates calcium entry and 
release from the sarcoplasmic reticulum. Coupling of 
oxytocin to its receptor activates phospholipase-Cȕ, which 
hydrolyses phosphatidylinositol bisphosphate (PIP
2
) 
releasing two second messengers, inositol triphosphate 
(IP
3





 from the sarcoplasmic reticulum, which 
proceeds to open up more extracellular calcium channels, 
while DAG activates protein kinase C (Wray & Arrowsmith 
2010). Oxytocin has also been reported to exert a stimulatory 
effect on [Ca2+]
i
 entry and release from the sarcoplasmic 
reticulum (Soloff & Sweet 1982) while also inhibiting [Ca2+]
i
 
efflux, which may result in the inhibition of myosin light 
chain phosphate (Wray & Arrowsmith 2010). The net effect 
is a powerful enhancement of force and slowing relaxation 
which could be observed in this study. The effect of DF on 
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FIGURE 6:KƌŝŐŝŶĂůƌĞƉƌĞƐĞŶƚĂƟǀĞƌĞĐŽƌĚŝŶŐƐŚŽǁŝŶŐƚŚĞĞīĞĐƚŽĨ ?Įůŝǆ ?ŵĂƐ
 ?& ZŽŶŽǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟŽŶŝŶĐĂůĐŝƵŵ ?ĚĞƉƌŝǀĞĚŵĞĚŝƵŵ ?&
ĂƉƉĞĂƌĞĚ ƚŽ ŚĂǀĞ ůŝƩůĞ ĞīĞĐƚ ŽŶ ŽǆǇƚŽĐŝŶ ǁŚĞŶ Ă ĐĂůĐŝƵŵ ?ĨƌĞĞ ŵĞĚŝƵŵ ǁĂƐ
ƵƐĞĚ ?ĂůƚŚŽƵŐŚƐůŝŐŚƚĚĞƉƌĞƐƐŝŽŶƐǁĞƌĞŽďƐĞƌǀĞĚĂƚƚŚĞŚŝŐŚĞƐƚĐŽŶĐĞŶƚƌĂƟŽŶƐ
ŽĨ&ƵƐĞĚŝŶƚŚŝƐƐƚƵĚǇ ?n A䄀  ?ĂŶŝŵĂůƐ ?
d> ? PWƵƚĂƟǀĞůǇŝĚĞŶƟĮĞĚĐŽŵƉŽƵŶĚƐŝŶƌǇŽƉƚĞƌŝƐĮůŝǆ ?ŵĂƐ ?
Serial Number Compound name Molecular formula Molecular weight (g/mol) ŵ ?ǌ Zd ?ŵŝŶ ?
 ? ?  ? ?ĂĐĞƚǇů ? ? ? ? ?ŽĐƚĂĚŝĞŶŽŝĐĂĐŝĚ C ? ?, ? ?O3  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ?
 ? ? ĂƵƌĂŶƟĂŵŝĚĞ ?K ?ĂĐĞƚǇů C ? ?, ? ?E ?O4  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ƚƌŝůůĞŶŽŐĞŶŝŶ ? ?ɴ ?ŚǇĚƌŽǆǇ ? ? ?K ? ?ɴ ? ?ĂƉŝŽĨƵƌĂŶŽƐǇů ? ? ?AP ? Z ?ɲ ?>
ƌŚĂŵŶŽƉǇƌĂŶŽƐǇů ? ? ?AP ? Z ? ?ɴ ? ?ǆǇůŽƉǇƌĂŶŽƐǇů ? ? ?AP ? Z ? ?ɲ ?> ?
ĂƌĂďŝŶŽƉǇƌĂŶŽƐŝĚĞ ?
C ? ?, ? ?O ? ?  ? ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ĂƐƉĞƌƉŚĞŶĂŵĂƚĞ C ? ?, ? ?E ?O4  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ?  ? ? ? ? ? ?ĐǇĐůŽ ? ? ? ? ? ? ?ĚŝŚǇĚƌŽǆǇ ? ? ? ? ?ĚŝŶŽƌ ? ? ?ƉŚǇƚĞŶ ? ? ?ŽŶĞ C ? ?, ? ?O3  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ĚĞƟŐůŽǇů ? ? ?ĚĞŽǆǇ ? ? ?ŚǇĚƌŽǆǇƐǁŝĞƚĞŶŝŶĞ C
34
, ? ?O ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ?  ? ? ? ? ?AP ? ? Z ?ĂďĞŽ ? ? ? ? ? ? ?ĞƉŽǆǇ ? ? ? ? ? ?ĚŝŚǇĚƌŽǆǇĐŚŽůĞƐƚĂ ? ? ? ? ? ?ĚŝĞŶ ? ? ? ĂůC ? ?, ? ?O4  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ĐŚůŽƌŽĐƌƵŽƌŽƉŽƌƉŚǇƌŝŶ ?ŝ ?DĞĞƐƚĞƌ C ? ?, ? ?E4O ?  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ?  ? ? ?ŚǇĚƌŽǆǇŝŶŐĞŶŽů ? ? ? ?ďĞŶǌŽǇů ? ? ?ĂŶŐĞůŽǇů ? ? ?Đ C
34
, ? ?O ?  ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?








 ? ? ? ? ? ? ? ?  ? ? ? ? ? ? ? ?  ? ? ? ? ?
Zd ?ƌĞƚĞŶƟŽŶƟŵĞ ?
d> ? PhŶŝĚĞŶƟĮĞĚĐŽŵƉŽƵŶĚƐŝŶƌǇŽƉƚĞƌŝƐĮůŝǆ ?ŵĂƐ ?ŽƵďůĞďŽŶĚĞƋƵŝǀĂůĞŶĐĞŝŶĚŝĐĂƚĞƐŶƵŵďĞƌŽĨƌŝŶŐƐĂŶĚĚŽƵďůĞďŽŶĚƐŝŶƚŚĞƐƚƌƵĐƚƵƌĞ ?ǁŚĞƌĞ ?ƌŝŶŐA䄀  ?ĚŽƵďůĞ
ďŽŶĚĞƋƵŝǀĂůĞŶĐĞ ?
Serial Number Predicted molecular formula Double bond equivalence Molecular weight (g/mol) ŵ ?ǌ Zd ?ŵŝŶ ?
 ? ? ? C ? ?, ? ?E3O ?  ? ? ? ? ? ? ? ?  ?D ?, ? ? ? ? ?  ? ? ? ?  ? ? ? ? ?
 ? ? ? C ? ?, ? ?E4O ?  ? ? ? ?  ? ? ? ? ? ? ? ?  ?DA㴀H ?A?  ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ? C ? ?, ? ?EK ?  ? ? ? ?  ? ? ? ? ? ? ? ?  ?D ?, ? ? ? ? ?  ? ? ? ?  ? ? ? ? ?
 ? ? ? C ? ?, ? ?E ?O3  ? ? ? ?  ? ? ? ? ? ? ? ?  ?DA㴀H ?A?  ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ? C
33
, ? ?E ?O ?  ? ? ? ?  ? ? ? ? ? ? ? ?  ?DA㴀H ?A?  ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ? C ? ?,34E3O3  ? ? ? ?  ? ? ? ? ? ? ? ?  ?DA㴀H ?A?  ? ? ? ? ? ? ?  ? ? ? ? ?
 ? ? ? C ? ?, ? ?E3O4  ? ? ? ?  ? ? ? ? ? ? ? ?  ?D ?, ? ? ? ? ?  ? ? ? ?  ? ? ? ? ?
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developing hypothesis that DF may be involved in the 
prevention of MLCK activation. However, the effect of DF 
on oxytocin also suggests possible interaction with the 
associated second messengers IP
3
 and DAG, but this 
remains to be investigated.
KCI-rich solutions have been reported to depolarise the 
surface membrane of muscle cells resulting in contraction 
(Niedergerke 1956). The resting membrane potential of 
uterine smooth muscle cells has been recorded to be between 
-35 mV and -80 mV (Togashi 2007). Potassium-rich solutions 
cause changes in the ionic permeability of the myocyte 
membrane, which leads to the threshold for action potential 
generation being reached, resulting in the depolarisation of 
the cell membrane, markedly increased Ca2+ entry, and 
subsequent contraction (Arrowsmith et al. 2014). Together, 
these result in what is known as a ‘complex action potential’ 
which involves an initial spike-like depolarisation followed 
by a sustained plateau of depolarisation between -30 mV and 
-20 mV, and involves strong Ca2+ conductance (Arrowsmith 
et al. 2014) through the voltage-operated calcium channels 
(VOCs), in particular, the L-type calcium channel (Granger, 
Hollingsworth & Weston 1986). Gap junctions within the 
myocytes ensure propagation of the action potentials 
throughout the myometrium, prompting contraction 
synchronicity at the whole organ level (Arrowsmith et al. 
2014; Little, Teaf & Hurwitz 1985). This mechanical response 
to high K+ is completely inhibited by several calcium channel 
blockers through blockade of the L-type channel (Calixto & 
Sirley 1985). This therefore proposes potential inhibitory 
activity of DF on VOC which would have been responsible 
for the inhibition of KCl-induced contractions in this study.
In a calcium-deprived medium, the only available calcium 
originates from intracellular stores (Batra 1986). In this 
study, oxytocin was shown to produce contractions in 
the calcium-free solution suggesting the utilisation of 
intracellular calcium stores which has been previously 
documented (Arrowsmith & Wray 2014; Arrowsmith et al. 
2014). The uterine sarcoplasmic reticulum actively takes up 
and stores Ca2+ by using the sarcoplasmic/endoplasmic 
reticulum Ca2+-ATPase (SERCA), and luminal Ca2+ buffers. 
It is also well endowed with Ca-release channels with the 
major effect of IP
3
 being to trigger Ca2+ release from the 
sarcoplasmic reticulum via the IP
3
 receptors (Arrowsmith et 
al. 2014). DF was observed to have no significant effect on 
oxytocin-induced contraction under these conditions, 
suggesting a lack of interaction with [Ca2+]
i 
and rather a 
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Taken together, it appears that DF may exhibit uterine 
inhibitory activity particularly through interaction with 
extracellular voltage-gated calcium channels, presumably 
the L-type calcium channels that are responsible for 
spontaneous contractions. Spontaneous contractions have 
been reported to have no involvement with intracellular 
calcium (Shmigol, Eisner & Wray 2001) suggesting that 
myogenic phasic contractions of the uterus are entirely 
dependent on Ca2+ influx through voltage-gated L-type 
Ca2+ channels, which are necessary and sufficient for 
normal spontaneous myometrial activity (Kupittayanant, 
Burdyga & Wray 2001; Shmigol, Eisner & Wray 1998). 
However, agonists (such as oxytocin) promote re-uptake 
of Ca2+ into the sarcoplasmic reticulum via the Ca2+-
ATPase of the sarcoplasmic reticulum (Shmygol & Wray 
2004) suggesting a strong dependence of agonist on 
intracellular calcium (Arrowsmith et al. 2014). In this 
study, it was observed that under the influence of 
extracellular calcium channels on oxytocin activity, DF 
produced an inhibitory effect but in the absence of 
extracellular calcium, DF lacked activity on oxytocin. 
That DF could inhibit high K+-induced contraction which 
is highly dependent on calcium from extracellular 
channels also supports the involvement of DF with VOCs. 
There are currently no scientific reports on the effect of DF 
on myometrial contractility; however, an earlier study 
reported the anthelminthic effect of DF (Urban et al. 2008), 
which supports possible calcium inhibitory effect. Studies 
performed with Verbascum thapsus showed a similar 
anthelminthic activity and also reported, in addition, the 
possible inhibition of VOCs by the same plant V. thapsus 
(Ali et al. 2012), giving credence to the interaction of DF 
with VOCs suggested in this study.
ŝŽůŽŐŝĐĂůĞīĞĐƚƐŽĨŝĚĞŶƟĮĞĚĐŽŵƉŽƵŶĚƐŝŶ
 ?Įůŝǆ ?ŵĂƐ
Several compounds were identified in DF belonging to 
general classes of fatty acids, alkaloids, saponin glycoside, 
amino acids, limonoids and terpenes, as well as porphyrins. 
Some reported biological effects of the identified compounds 
are briefly discussed here in order to extrapolate possible 
relationship with the activity of DF in this study. 
Aurantiamide identified in DF belongs to the alkaloid group 
of compounds (Liu et al. 2015), and while there is not much 
work performed on the effect of aurantiamide on the uterus, 
it was reported that aurantiamide acetate inhibits the release 
of pro-inflammatory cytokines, nitric oxide and prostaglandin 
E
2
 (Liu et al. 2015), which may contribute to the inhibitory 
effect observed in this study. The trillenogenin also identified 
in DF is a steroid saponin polyglycoside (Wang et al. 2007), 
and similar to aurantiamide there has been no report on its 
actions on the uterus. However, it has been reported to 
inhibit cylclooxygenase 2 (COX-2) production (Wang et al. 
2007) and therefore may contribute to alteration of uterine 
contractility. Labour is associated with increased synthesis of 
prostaglandin in utero (Keirse, Mitchell & Turnbull 1977). 
Prostaglandins which are formed from the precursor 
arachidonic acid, which is itself is a substrate for at least 
three enzyme groups (Slater et al. 1999), are known to 
facilitate cervical ripening, stimulate uterine contractions 
(Crankshaw & Dyal 1994) and indirectly increase fundally 
dominant myometrial contractility via up-regulation of 
oxytocin receptors (Garfield, Tabb & Thilander 1990). 
The cyclooxygenase (COX) pathway releases prostaglandins. 
It has been reported that in labour, arachidonic acid 
metabolism is increased and the ratio of COX to lipoxygenase 
metabolism is changed such that it favours prostaglandin E
2
 
synthesis (Bennett et al. 1993). The expression of COX-2 
therefore increases drastically during labour (Hirst et al. 
1995), which potentiates uterine contraction. Inhibition 
of COX-2 will therefore lead to an inhibition of uterine 
contractility. Asperphenamate is a phenylalanine derivative 
(Zheng et al. 2013) identified in DF. It is an unusual ester of 
N-benzoylphenylalanine and N-benzoylphenylalaninol and 
was first isolated from Aspergillus flavipes (Clark, Hufford & 
Robertson 1977). It is known majorly for its antitumor 
activity (Li et al. 2012; Wu et al. 2004; Yuan, Wang & Sun 
2010), but there are currently no reports on the effect of 
asperphenamate on uterine contraction. Destigloylswietenine 
belongs to the limonoid class of plant secondary metabolites 
(Zhang et al. 2009) with swietenine being first isolated 
from the seeds of Swetenia macrophylla in 1964 (Conolly et al. 
1964). While there are also no reports of the effect of 
destigloylswietenine on uterine contraction, limonoids from 
Swietenia humilis (Meliaceae) have been reported to cause a 
stimulatory effect on intestinal and uterine smooth muscle, 
and it was suggested to occur possibly through an interaction 
with oestrogens (Perusquía et al. 1997). The chlorocruorins 
are green blood-pigments which resemble the haemoglobins 
and erythrocruorins in having a ferrous iron-porphyrin 
complex as prosthetic group, but the porphyrin, 
chlorocruoroporphyrin, which was identified in DF is 
different from that of haem (Walsh 1961). Phylloerythrin 
identified in DF also belongs to the porphyrin group of 
secondary metabolites and finds clinical application 
currently in photodynamic therapy (Smith et al. 1996). The 
porphyrin group of compounds has been reported to have 
varying effects of inhibition and stimulation on uterine 
contractility (Bafor et al. 2014); chlorocruoroporphyrin and 
phylloerythrin may therefore contribute to the activity of 
DF on the uterine smooth muscle. Hydroxyingenol also 
identified in DF belongs to the diterpene class of plant 
secondary metabolites which are reported to exhibit 
analgesic and anti-writhing activity and to also inhibit 
phorbol dibutyrate receptors (Mbwambo et al. 1996; Wu 
et al. 1991). The phorbol esters are potent analogues of 
diacylglycerol and also bind actively to protein kinase C 
receptors (Ono et al. 1989), which promotes Ca2+ release and 
smooth muscle contraction. Therefore, inhibition of the 
phorbol dibutyrate receptors may lead to an inhibition 
of contractility and may contribute to the effect of DF in 
this study. Earlier studies reported significant antioxidant 
activity of DF possibly because of the presence of several 
phenolic compounds (Sekendar Ali et al. 2012; Soare et al. 
2012). These support the compounds detected in these 
studies, which had varied components of phenol groups.
WĂŐĞ ? ?ŽĨ ? ? KƌŝŐŝŶĂůZĞƐĞĂƌĐŚ
ŚƩƉ P ? ?ǁǁǁ ?ũŽŵƉĞĚ ?ĐŽ ?ǌĂ KƉĞŶĐĐĞƐƐ
Conclusion
This study reports the inhibitory effect of the methanol leaf 
extract of DF on uterine contractility. DF was shown in this 
study to inhibit spontaneous, oxytocin-induced and high KCl-
induced uterine contractions. DF was however shown to have 
no effect on oxytocin-induced contraction in calcium-free 
media. Taken together, this study reports the inhibitory effect 
of DF on uterine contractility and suggests possible interaction 
with calcium with preference to the extracellular voltage-
gated calcium channels. Several secondary metabolites were 
also identified in DF which were found to include fatty acids, 
alkaloids, saponin glycoside, amino acids, limonoids, terpenes 
and porphyrins. Inhibition shown by DF in this study 
may therefore not support the reported traditional use in 
postpartum haemorrhage and uterine stimulation.
Acknowledgements
The authors wish to acknowledge the technical assistance of 
Miss Uyi Omogiade during this research.
ŽŵƉĞƟŶŐŝŶƚĞƌĞƐƚƐ
The authors declare that they have no financial or personal 
relationships which may have inappropriately influenced 
them in writing this article.
ƵƚŚŽƌ ?ƐĐŽŶƚƌŝďƵƟŽŶƐ
B.E.E. conceptualised and designed the study, participated in 
the experiments, analysed the data and wrote the article. 
O.O.W. participated in the experiments and data analysis. 
U.O.H. was primarily involved in the plant collection, 
preparation and extraction. E.U.B. and O.O. participated in 
the uterine contractility experiments. V.C. and E.R. were 
involved in the mass spectrometry experiments, interpretation 
of data and contributed in writing the article.
References
ŐƵŝůĂƌ ?, ?E ? ?DŝƚĐŚĞůů ? ?& ? ? ? ? ? ? ? RWŚǇƐŝŽůŽŐŝĐĂůƉĂƚŚǁĂǇƐĂŶĚŵŽůĞĐƵůĂƌŵĞĐŚĂŶŝƐŵƐ
ƌĞŐƵůĂƟŶŐ ƵƚĞƌŝŶĞ ĐŽŶƚƌĂĐƟůŝƚǇ ? ?,ƵŵĂŶ ZĞƉƌŽĚƵĐƟŽŶ hƉĚĂƚĞ  ? ? ?  ? ? ? W ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ŚƵŵƵƉĚ ?ĚŵƋ ? ? ?
ůŝ ?E ? ?ůŝ^ŚĂŚ ?^ ? ?^ŚĂŚ ?/ ? ?ŚŵĞĚ ?' ? ?'ŚŝĂƐ ?D ? ?<ŚĂŶ ?/ ?ĞƚĂů ? ? ? ? ? ? ? RŶƚŚĞůŵŝŶƟĐ
ĂŶĚƌĞůĂǆĂŶƚĂĐƟǀŝƟĞƐŽĨsĞƌďĂƐĐƵŵdŚĂƉƐƵƐDƵůůĞŝŶ ? ?DŽŵƉůĞŵĞŶƚĂƌǇĂŶĚůƚĞƌŶĂƟǀĞDĞĚŝĐŝŶĞ ? ? ? ? Z ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
ƌƌŽǁƐŵŝƚŚ ? ^ ? ? <ĞŶĚƌŝĐŬ ?  ? ? ,ĂŶůĞǇ ? : ? ? EŽďůĞ ? < ?  ?tƌĂǇ ? ^ ? ?  ? ? ? ? ?  RDǇŽŵĞƚƌŝĂů
ƉŚǇƐŝŽůŽŐǇ WdŝŵĞƚŽƚƌĂŶƐůĂƚĞ ? ? ?ǆƉĞƌŝŵĞŶƚĂůWŚǇƐŝŽůŽŐǇ ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?
ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ĞǆƉƉŚǇƐŝŽů ? ? ? ? ? ? ? ? ? ? ? ?
ƌƌŽǁƐŵŝƚŚ ? ^ ?  ? tƌĂǇ ? ^ ? ?  ? ? ? ? ?  RKǆǇƚŽĐŝŶ P /ƚƐ ŵĞĐŚĂŶŝƐŵ ŽĨ ĂĐƟŽŶ ĂŶĚ ƌĞĐĞƉƚŽƌ
ƐŝŐŶĂůůŝŶŐ ŝŶ ƚŚĞ ŵǇŽŵĞƚƌŝƵŵ ? ?:ŽƵƌŶĂů ŽĨ EĞƵƌŽĞŶĚŽĐƌŝŶŽůŽŐǇ  ? ? ?  ? ? ? W ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũŶĞ ? ? ? ? ? ?
ĂĨŽƌ ?  ? ? ? ďŝĚĂŵĞ ? s ?K ? ? ůǀŝƐ ?KĸĂŚ ? h ? ? ? KŵŽƌƵǇŝ ?K ? ? ǌĞ ? ' / ? ? /ŐďŝŶƵǁĞŶ ? K ?
ĞƚĂů ? ? ? ? ? ? ? RƌŽůĞŽĨĂůƉŚĂ ?ƚŽĐŽƉŚĞƌŽůĂŶĚƉŚǇůůŽƋƵŝŶŽŶĞŝŶƚŚĞŵŽĚƵůĂƟŽŶŽĨ
ƵƚĞƌŝŶĞ ĐŽŶƚƌĂĐƟůŝƚǇ ĂŶĚ ƌĞƉƌŽĚƵĐƟǀĞ ĨƵŶĐƟŽŶ ŝŶ ŵŽƵƐĞ ŵŽĚĞůƐ ? ?DĞĚŝĐŝŶĂ
(Buenos Aires) ? ? ? ? Z ? ? ? ? W ? ? ? ?
ĂĨŽƌ ?  ? ? ? >ŝŵ ?  ?s ? ? ZŽǁĂŶ ?  ?' ?  ? ĚƌĂĚĂ ?ďĞů ? Z ? ? ? ? ? ? ?  RdŚĞ ůĞĂǀĞƐ ŽĨ&ŝĐƵƐĞǆĂƐƉĞƌĂƚĂ sĂŚů  ?DŽƌĂĐĞĂĞ Z ŐĞŶĞƌĂƚĞƐ ƵƚĞƌŝŶĞ ĂĐƟǀĞ ĐŚĞŵŝĐĂů ĐŽŶƐƟƚƵĞŶƚƐ ? ?:ŽƵƌŶĂů ŽĨ ƚŚŶŽƉŚĂƌŵĂĐŽůŽŐǇ  ? ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ?
ũĞƉ ? ? ? ? ? ? ? ? ? ? ? ?
ĂĨŽƌ ?  ? ? ? KŵŽŐďĂŝ ?  ?< ?/ ?  ? KǌŽůƵĂ ? Z ?/ ? ?  ? ? ? ? ?  RIn vitro ĚĞƚĞƌŵŝŶĂƟŽŶ ŽĨ ƚŚĞ
ƵƚĞƌŝŶĞ ƐƟŵƵůĂƚŽƌǇ ĞīĞĐƚ ŽĨ ƚŚĞ ĂƋƵĞŽƵƐ ůĞĂĨ ĞǆƚƌĂĐƚ ŽĨ &ŝĐƵƐ ĞǆĂƐƉĞƌĂƚĂ ? ?:ŽƵƌŶĂů ŽĨ ƚŚŶŽƉŚĂƌŵĂĐŽůŽŐǇ  ? ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ?
ũĞƉ ? ? ? ? ? ? ? ? ? ? ? ?
ĂƚƌĂ ?^ ? ? ? ? ? ? ? RīĞĐƚŽĨŽǆǇƚŽĐŝŶŽŶĐĂůĐŝƵŵŝŶŇƵǆĂŶĚĞŋƵǆŝŶ ƚŚĞƌĂƚŵǇŽŵĞƚƌŝƵŵ ? ?ƵƌŽƉĞĂŶ:ŽƵƌŶĂůŽĨWŚĂƌŵĂĐŽůŽŐǇ ? ? ? ? ? Z ? ? ? W ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ? ? ? ? ?
 ? ? ? ? ? ? ? Z ? ? ? ? ? ? ?
ĞŶŶĞƩ ?W ?Z ? ?^ůĂƚĞƌ ? ?D ? ?^ƵůůŝǀĂŶ ?D ?, ?& ? ?ůĚĞƌ ?D ?' ? DŽŽƌĞ '  ? ? ? ? ? ? ? RŚĂŶŐĞƐ
ŝŶ ĂƌĂĐŚŝĚŽŶŝĐ ĂĐŝĚ ŵĞƚĂďŽůŝƐŵ ŝŶ ĂŵŶŝŽŶ ĐĞůůƐ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ ŝŶĐƌĞĂƐĞĚ
ĐǇĐůŽŽǆǇŐĞŶĂƐĞ ŐĞŶĞ ĞǆƉƌĞƐƐŝŽŶ Ăƚ ƉĂƌƚƵƌŝƟŽŶ ? ?ƌŝƟƐŚ :ŽƵƌŶĂů ŽĨ KďƐƚĞƚƌŝĐƐĂŶĚ 'ǇŶĂĞĐŽůŽŐǇ  ? ? ? ?  ? ? ? ? W ? ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
ƚď ? ? ? ? ? ?ǆ
ƵůůĞƫ ? ? ?ŝĞŐůĞƌ ? ? ?WŽůůŝ ? s ? ?ŝŽƚĂůůĞǀŝ ? > ?  ?&ƌƌŽ ? ?   ? ? ? ? ?  R&ůĂŵŝŐŶŝ  ? hƚĞƌŝŶĞ
ĐŽŶƚƌĂĐƟůŝƚǇĚƵƌŝŶŐƚŚĞŵĞŶƐƚƌƵĂůĐǇĐůĞ ? ?,ƵŵĂŶZĞƉƌŽĚƵĐƟŽŶ ? ? ? ? ? W ? ? ?ŚƩƉƐ P ? ?
ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ŚƵŵƌĞƉ ? ? ? ?ƐƵƉƉů Y ? ? ? ?
ƵƌĚǇŐĂ ?d ? ?tƌĂǇ ?^ ? ?EŽďůĞ ?< ? ? ? ? ? ? ? RIn situĐĂůĐŝƵŵƐŝŐŶĂůŝŶŐ PEŽĐĂůĐŝƵŵƐƉĂƌŬƐ
ĚĞƚĞĐƚĞĚ ŝŶ ƌĂƚ ŵǇŽŵĞƚƌŝƵŵ ? ?ŶŶĂůƐ ŽĨ ƚŚĞ EĞǁ zŽƌŬ ĐĂĚĞŵǇ ŽĨ ^ĐŝĞŶĐĞƐ
 ? ? ? ? ? ? Z P ? ? W ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ĂŶŶĂůƐ ? ? ? ? ? ? ? ? ?
ƵƚůĞƌ ?d ? ?WĂƵů ? : ? ?ƵƌŽƉĞ ?&ŝŶŶĞƌ ?E ? ?^ŵŝƚŚ ?Z ?  ?ŚĂŶ   ? ? ?  ? ? ? ? ?  RZŽůĞŽĨ ƐĞƌŝŶĞ ?
ƚŚƌĞŽŶŝŶĞ ƉŚŽƐƉŚŽƉƌŽƚĞŝŶ ƉŚŽƐƉŚĂƚĂƐĞƐ ŝŶ ƐŵŽŽƚŚ ŵƵƐĐůĞ ĐŽŶƚƌĂĐƟůŝƚǇ ? ?ŵĞƌŝĐĂŶ :ŽƵƌŶĂů ŽĨ WŚǇƐŝŽůŽŐǇ ?Ğůů WŚǇƐŝŽůŽŐǇ  ? ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?ĂũƉĐĞůů ? ? ? ? ? ? ? ? ? ? ?
ĂůŝŐŝŽŶŝ ? ?^ ? ? ? ? ? ? ? RƐƐĞƐƐŝŶŐƌĞƉƌŽĚƵĐƟǀĞƐƚĂƚƵƐ ?ƐƚĂŐĞƐŝŶŵŝĐĞ ? ?ƵƌƌĞŶƚWƌŽƚŽĐŽůƐŝŶEĞƵƌŽƐĐŝĞŶĐĞƉƉĞŶĚŝǆ ? ?ƉƉĞŶĚŝǆ ?/ ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
ŶƐĂ ? ?ŝƐ ? ?
ĂůŝǆƚŽ ?: ? ? ?^ŝƌůĞǇ ?> ? ? ? ? ? ? ? R<ĞƚĂŵŝŶĞ ?ŝŶŚŝďŝƟŽŶŽĨĐĂůĐŝƵŵ ?ŝŶĚƵĐĞĚĐŽŶƚƌĂĐƟŽŶƐŝŶ
ĚĞƉŽůĂƌŝǌĞĚ ƌĂƚ ƵƚĞƌƵƐ P  ĐŽŵƉĂƌŝƐŽŶ ǁŝƚŚ ŽƚŚĞƌ ĐĂůĐŝƵŵ ĂŶƚĂŐŽŶŝƐƚƐ ? ?ƌŝƟƐŚ:ŽƵƌŶĂů ŽĨ WŚĂƌŵĂĐŽůŽŐǇ  ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ? ? ? ? ? ?
 ? ? ? ? ? ? ? ? ? ?ƚď ? ? ? ? ? ?ǆ
ůĂƌŬ ? ?D ? ?,ƵīŽƌĚ ? ? ? ?ZŽďĞƌƚƐŽŶ ?t ? ? ? ? ? ? ? RdǁŽŵĞƚĂďŽůŝƚĞƐĨƌŽŵƐƉĞƌŐŝůůƵƐŇĂǀŝƉĞ ? ?>ůŽǇĚŝĂ ? ? ? ? Z ? ? ? ? ?
ŽĐŬ ? / ? ? ?  ? ? ? ? ?  RdŚĞ ƐĂĨĞ ƵƐĂŐĞ ŽĨ ŚĞƌďĂů ŵĞĚŝĐŝŶĞƐ P ŽƵ ƚĞƌ ?ŝŶĚŝĐĂƟŽŶƐ ? ĐƌŽƐƐ ?
ƌĞĂĐƟǀŝƚǇĂŶĚƚŽǆŝĐŝƚǇ ? ?WŚĂƌŵĂĐŽŐŶŽƐǇŽŵŵƵŶŝĐĂƟŽŶƐ ?ǀŝĞǁĞĚ ? ?DĂƌĐŚ ? ? ? ? ?
ĨƌŽŵŚƩƉ P ? ?ǁǁǁ ?ƉŚĐŽŐĐŽŵŵŶ ?ŽƌŐ ?ƐŝƚĞƐ ?ĚĞĨĂƵůƚ ?ĮůĞƐ ? ? ? ? ? ? ? ? ?ƉĐ Y ? ? ? ? ? ? ? ? ? ?ƉĚĨ
ŽŶŽůůǇ ?: ? ? ?,ĞŶĚĞƌƐŽŶ ?Z ? ?DĐƌŝŶĚůĞ ?Z ? ?KǀĞƌƚŽŶ ?< ?, ?  ?ŚĂĐĂ ?E ?^ ? ?  ? ? ? ? ?  RdŚĞ
ĐŽŶƐƟƚƵƟŽŶŽĨƐǁŝĞƚĞŶŝŶĞ ?ĂŶŽǀĞůƚĞƚƌĂŶŽƌƚƌŝƚĞƌƉĞŶŽŝĚ ? ?dĞƚƌĂŚĞĚƌŽŶ>ĞƩĞƌƐ ? ? ?
 ? ? ? ? W ? ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?^ ? ? ? ? ? ? ? ? ? ? ? ? Z ? ? ? ? ? ? ?
ŽƌĂ ?D ? ? ?<ŽŽŝƐƚƌĂ ?> ? ?dƌĂǀůŽƐ ?' ? ? ? ? ? ? ? RsĂŐŝŶĂůĐǇƚŽůŽŐǇŽĨƚŚĞ ůĂďŽƌĂƚŽƌǇƌĂƚĂŶĚ
ŵŽƵƐĞ P ZĞǀŝĞǁ ĂŶĚ ĐƌŝƚĞƌŝĂ ĨŽƌ ƚŚĞ ƐƚĂŐŝŶŐ ŽĨ ƚŚĞ ĞƐƚƌŽƵƐ ĐǇĐůĞ ƵƐŝŶŐ ƐƚĂŝŶĞĚ
ǀĂŐŝŶĂů ƐŵĞĂƌƐ ? ?dŽǆŝĐŽůŽŐŝĐ WĂƚŚŽůŽŐǇ  ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ PĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?
 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
ƌĂŶŬƐŚĂǁ ? ?: ? ?ǇĂů ?Z ? ? ? ? ? ? ? RīĞĐƚƐŽĨƐŽŵĞŶĂƚƵƌĂůůǇŽĐĐƵƌƌŝŶŐƉƌŽƐƚĂŶŽŝĚƐĂŶĚ
ƐŽŵĞĐǇĐůŽ ?ŽǆǇŐĞŶĂƐĞŝŶŚŝďŝƚŽƌƐŽŶƚŚĞĐŽŶƚƌĂĐƟůŝƚǇŽĨƚŚĞŚƵŵĂŶůŽǁĞƌƵƚĞƌŝŶĞ
ƐĞŐŵĞŶƚin vitro ? ?ĂŶĂĚŝĂŶ:ŽƵƌŶĂůŽĨWŚǇƐŝŽůŽŐǇĂŶĚWŚĂƌŵĂĐŽůŽŐǇ ? ? ? ? ? ? W ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?Ǉ ? ? ? ? ? ?
ƌŝĐŚƚŽŶ ? ? ? ?dĂŐŐĂƌƚ ?D ?: ? ?tƌĂǇ ?^ ? ?^ŵŝƚŚ ?' ?> ? ? ? ? ? ? ? RīĞĐƚƐŽĨƉ,ĂŶĚŝŶŽƌŐĂŶŝĐ
ƉŚŽƐƉŚĂƚĞŽŶĨŽƌĐĞƉƌŽĚƵĐƟŽŶŝŶĂůƉŚĂ ?ƚŽǆŝŶ ?ƉĞƌŵĞĂďŝůŝǌĞĚŝƐŽůĂƚĞĚƌĂƚƵƚĞƌŝŶĞ
ƐŵŽŽƚŚ ŵƵƐĐůĞ ? ?:ŽƵƌŶĂů WŚǇƐŝŽůŽŐǇ  ? ? ? ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?
ũƉŚǇƐŝŽů ? ? ? ? ? ?ƐƉ ? ? ? ? ? ?
ĞsƌŝĞƐ ?< ? ?>ǇŽŶƐ ? ? ? ?ĂůůĂƌĚ ?' ? ?>Ğǀŝ ? ?^ ? ?>ŝŶĚƐĂǇ ? :  ? ? ? ? ? ? RŽŶƚƌĂĐƟŽŶƐŽĨƚŚĞ
ŝŶŶĞƌƚŚŝƌĚŽĨƚŚĞŵǇŽŵĞƚƌŝƵŵ ? ?ŵĞƌŝĐĂŶ:ŽƵƌŶĂůŽĨKďƐƚĞƚƌŝĐƐĂŶĚ'ǇŶĞĐŽůŽŐǇ
 ? ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Z ? ? ? ? ? ?
ƵŐŽƵĂ ? : ?: ? ?  ? ? ? ? ?  R,ĞƌďĂů ŵĞĚŝĐŝŶĞƐ ĂŶĚ ƉƌĞŐŶĂŶĐǇ ? ?:ŽƵƌŶĂů ŽĨ WŽƉƵůĂƟŽŶdŚĞƌĂƉĞƵƟĐƐĂŶĚůŝŶŝĐĂůWŚĂƌŵĂĐŽůŽŐǇ ? ? ? ? Z ?Ğ ? ? ? WĞ ? ? ?
ƵŬĞ ?: ? ? ? ? ? ? ? ?,ĂŶĚďŽŽŬŽĨŵĞĚŝĐŝŶĂůŚĞƌďƐ ?,ĞƌďĂůZĞĨĞƌĞŶĐĞ>ŝďƌĂƌǇ ?ZWƌĞƐƐ ?
&ůŽƌŝĚĂh^ ?Ɖ ? ? ? ? ?
ůǀŝƐ ?KĸĂŚ ?h ? ? ? /ǇĂǁĞ ?s ?/ ?  ?ĂĨŽƌ ? ? ? ?  ? ? ? ? ?  RIn vitro ƌĞƐƉŽŶƐĞŽĨ ŝƐŽůĂƚĞĚŶŽŶ ?
ƉƌĞŐŶĂŶƚŵŽƵƐĞƵƚĞƌƵƐƚŽƚŚĞŵĞƚŚĂŶŽůĞǆƚƌĂĐƚŽĨŵŝůŝĂĐŽĐĐŝŶĞĂ ?^ŝŵƐ Z' ?ŽŶƐ
ůĞĂĨ ? ?:ŽƵƌŶĂůŽĨWŚĂƌŵĂĐǇ ?ŝŽƌĞƐŽƵƌĐĞƐ ? ? ? ? Z ? ? ? ? W ? ? ? ?
&ĂŬĞǇĞ ?d ?K ? ?ĚŝƐĂ ?Z ? ?DƵƐĂ ?/ ? ? ? ? ? ? ? ? RƫƚƵĚĞĂŶĚƵƐĞŽĨŚĞƌďĂůŵĞĚŝĐŝŶĞƐĂŵŽŶŐ
ƉƌĞŐŶĂŶƚǁŽŵĞŶŝŶEŝŐĞƌŝĂ ? ?DŽŵƉůĞŵĞŶƚĂƌǇĂŶĚůƚĞƌŶĂƟǀĞDĞĚŝĐŝŶĞ ? ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
'ĂƌĮĞůĚ ?Z ? ? ?dĂďď ?d ? ?dŚŝůĂŶĚĞƌ ?' ? ? ? ? ? ? ? R/ŶƚĞƌĐĞůůƵůĂƌĐŽƵƉůŝŶŐĂŶĚŵŽĚƵůĂƟŽŶŽĨ
ƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟůŝƚǇ ? ?ŝŶZ ? ?'ĂƌĮĞůĚ ?D ? ?EŽƌǁĞůů ?ĞĚƐ ? Z ?hƚ ƌŝŶĞĐŽŶƚƌĂĐƟůŝƚǇ ?
ƉƉ ? ? ? W ? ? ?^ĞƌŽŶŽ^ǇŵƉŽƐŝĂ ?DĂƐƐĂĐŚƵƐĞƩƐ ?h^ ?
'ƌĂŶŐĞƌ ? ^ ? ? ? ,ŽůůŝŶŐƐǁŽƌƚŚ ? D ?  ? tĞƐƚŽŶ ?  ?, ? ?  ? ? ? ? ?  RīĞĐƚƐ ŽĨ ĐĂůĐŝƵŵ ĞŶƚƌǇ
ďůŽĐŬĞƌƐŽŶƚĞŶƐŝŽŶĚĞǀĞůŽƉŵĞŶƚĂŶĚĐĂůĐŝƵŵŝŶŇƵǆŝŶƌĂƚƵƚĞƌƵƐ ? ?ƌŝƟƐŚ:ŽƵƌŶĂůŽĨ WŚĂƌŵĂĐŽůŽŐǇ  ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ? ? ? ? ? ? ? ? ? ? ?     
ƚď ? ? ? ? ? ?ǆ
hǁƵŵĂƌŽŶŐŝĞ ?, ? ?ŶŝŬĞ ?D ? ? ?ĂĨŽƌ ? ? ? ? ? ? ? ? ? RWŚĂƌŵĂĐŽŐŶŽƐƟĐĞǀĂůƵĂƟŽŶĂŶĚ
ŐĂƐƚŽŝŶƚĞƐƟŶĂů ĂĐƟǀŝƚǇ ŽĨ ƌǇŽƉƚĞƌŝƐ Įůŝǆ ?ŵĂƐ  ?> ? Z ^ĐŚŽƩ  ?ƌǇŽƉƚĞƌŝĚĂĐĞĂĞ Z ? ?ǁĞŵĞŶ:ŽƵƌŶĂůŽĨ,ĞƌďĂůŚĞŵŝƐƚƌǇ ?WŚĂƌŵĂĐŽůŽŐǇZĞƐĞĂƌĐŚ ? ? ? Z ? ? ? W ? ? ?
,ŝƌƐƚ ?: ?: ? ?dĞŝǆĞŝƌĂ ?& ?: ? ?ĂŬĂƌ ?d ? ?KůƐŽŶ ? ?D ? ? ? ? ? ? ? RWƌŽƐƚĂŐůĂŶĚŝŶĞŶĚŽƉĞƌŽǆŝĚĞ ?,
ƐǇŶƚŚĂƐĞ ? ?ĞǆƉƌĞƐƐŝŽŶŝŶĐƌĞĂƐĞƐŝŶŚƵŵĂŶŐĞƐƚĂƟŽŶĂůƟƐƐƵĞƐǁŝƚŚƐƉŽŶƚĂŶĞŽƵƐ
ůĂďŽƵƌŽŶƐĞƚ ? ?ZĞƉƌŽĚƵĐƟŽŶ ?&ĞƌƟůŝƚǇ ?ĂŶĚĞǀĞůŽƉŵĞŶƚ  ? ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?Z ? ? ? ? ? ? ?
:ŽŚŶƐŽŶ ?: ? ? ?^ŶǇĚĞƌ ? ? ?tĂůƐŚ ?D ? ?&ůǇŶŶ ?D ? ? ? ? ? ? ? RīĞĐƚƐŽĨŵǇŽƐŝŶůŝŐŚƚĐŚĂŝŶ
ŬŝŶĂƐĞĂŶĚƉĞƉƟĚĞƐŽŶĂ ?A㴀 ĞǆĐŚĂŶŐĞǁŝƚŚƚŚĞE ?ĂŶĚ ?ƚĞƌŵŝŶĂůĂ ?A㴀 ďŝŶĚŝŶŐ
ƐŝƚĞƐŽĨĐĂůŵŽĚƵůŝŶ ? ?:ŽƵƌŶĂůŽĨŝŽůŽŐŝĐĂůŚĞŵŝƐƚƌǇ ? ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?ũďĐ ? ? ? ? ? ? ? ? ? ?
<ĂŶƚĞŵŝƌ ?/ ? ?ŬĚĞƌ ?' ? ?dƵůƵŶĂǇ ?K ? ? ? ? ? ? ? RWƌĞůŝŵŝŶĂƌǇƌĞƉŽƌƚŽŶĂŶƵŶĞǆƉĞĐƚĞĚĞīĞĐƚ
ŽĨ ĂŶ ĞǆƚƌĂĐƚ ĨƌŽŵ ƌǇŽƉƚĞƌŝƐ Įůŝǆ ŵĂƐ  ?ĂƵƚŚŽƌ ?Ɛ ƚƌĂŶƐů Z ? ?ƌǌŶĞŝŵŝƩĞůĨŽƌƐĐŚƵŶŐ
 ? ? ? ? Z ? ? ? ? W ? ? ? ?
<ĞŝƌƐĞ ?D ?: ?E ? ? ?DŝƚĐŚĞůů ?D ? ? ?dƵƌŶďƵůů ? ? ? ? ? ? ? ? ? RŚĂŶŐĞƐŝŶƉƌŽƐƚĂŐůĂŶĚŝŶ&ĂŶĚ
 ? ? ?  ? ? ?ĚŝŚǇĚƌŽ ? ? ? ?ŬĞƚŽ ?ƉƌŽƐƚĂŐůĂŶĚŝŶ & ĐŽŶĐĞŶƚƌĂƟŽŶƐ ŝŶ ĂŵŶŝŽƟĐ ŇƵŝĚ Ăƚ ƚŚĞ
ŽŶƐĞƚŽĨĂŶĚĚƵƌŝŶŐůĂďŽƵƌ ? ?ƌŝƟƐŚ:ŽƵƌŶĂůŽĨKďƐƚĞƚƌŝĐƐĂŶĚ'ǇŶĂĞĐŽůŽŐǇ ? ? ? ? ? Z ?
 ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?ƚď ? ?    ǆ
<ĞƐƐŶĞƌ ?  ? ? ŚĂŵďĞƌƐ ? D ? ? ƵƌŬĞ ? Z ? ? ŐƵƐ ?  ?  ? DĂůůŝĐŬ ? W  ?  ? ? ? ? ?  RWƌŽƚĞŽtŝǌĂƌĚ P
KƉĞŶ ƐŽƵƌĐĞ ƐŽŌǁĂƌĞ ĨŽƌ ƌĂƉŝĚ ƉƌŽƚĞŽŵŝĐƐ ƚŽŽůƐ ĚĞǀĞůŽƉŵĞŶƚ ? ?ŝŽŝŶĨŽƌŵĂƟĐƐ
 ? ? ? ? ? Z ? ? ? ? ? W ? ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ďŝŽŝŶĨŽƌŵĂƟĐƐ ?ďƚŶ   ?
<ƵŶǌ ?' ? ?>ĞǇĞŶĚĞĐŬĞƌ ?' ? ? ? ? ? ? ? RhƚĞƌŝŶĞƉĞƌŝƐƚĂůƟĐĂĐƟǀŝ ǇĚƵƌŝŶŐƚŚĞŵĞŶƐƚƌƵĂůĐǇĐůĞ P
ŚĂƌĂĐƚĞƌŝǌĂƟŽŶ ?ƌĞŐƵůĂƟŽŶ ? ĨƵŶĐƟŽŶĂŶĚĚǇƐĨƵŶĐƟŽŶ ? ?ZĞƉƌŽĚƵĐƟǀĞŝŽŵĞĚŝĐŝŶĞKŶůŝŶĞ ? ?^ƵƉƉů ? Z ? ? W ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?^ ? ? ? ? ? ? ? ? ? ?   Z ?      
WĂŐĞ ? ?ŽĨ ? ? KƌŝŐŝŶĂůZĞƐĞĂƌĐŚ
ŚƩƉ P ? ?ǁǁǁ ?ũŽŵƉĞĚ ?ĐŽ ?ǌĂ KƉĞŶĐĐĞƐƐ
<ƵƉŝƩĂǇĂŶĂŶƚ ? ^ ? ? ƵƌĚǇŐĂ ? d ?  ? tƌĂǇ ? ^ ? ?  ? ? ? ? ?  RdŚĞ ĞīĞĐƚƐ ŽĨ ŝŶŚŝďŝƟŶŐ ZŚŽ ?
ĂƐƐŽĐŝĂƚĞĚ ŬŝŶĂƐĞ ǁŝƚŚ z ? ? ? ? ? ? ŽŶ ĨŽƌĐĞ ĂŶĚ ŝŶƚƌĂĐĞůůƵůĂƌĐ ůĐŝƵŵ ŝŶ ŚƵŵĂŶ
ŵǇŽŵĞƚƌŝƵŵ ? ?WŇƺŐĞƌƐƌĐŚŝǀ PƵƌŽƉĞĂŶ:ŽƵƌŶĂůŽĨWŚǇƐŝŽůŽŐǇ  ? ? ? ? ? Z ? ? ? ? W ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?Ɛ ? ? ? ? ? ? ? ? ? ? ? ?
>ŝ ?z ? ?>ƵŽ ?Y ? ?zƵĂŶ ?> ? ?DŝĂŽ ? ? ?DƵ ?y ? ?yŝĂŽ ?t ?ĞƚĂů ? ?  ? ? ?  ? R:E< ?ĚĞƉĞŶĚĞŶƚƚŐ ?
ƵƉƌĞŐƵůĂƟŽŶ ŵĞĚŝĂƚĞƐ ĂƐƉĞƌƉŚĞŶĂŵĂƚĞ ĚĞƌŝǀĂƟǀĞ W ?ŝŶĚƵĐĞĚ ĂƵƚŽƉŚĂŐǇ ŝŶ
D& ? ? ĐĞůůƐ ? ?dŽǆŝĐŽůŽŐǇ ĂŶĚ ƉƉůŝĞĚ WŚĂƌŵĂĐŽůŽŐǇ  ? ? ? ? ? Z ?  ? ? W ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ?ƚĂĂƉ ? ? ? ? ? ? ? ? ? ? ? ?
>ŝƩůĞ ?^ ? ? ?dĞĂĨ ? ?  ?,Ƶƌǁŝƚǌ ?> ? ?  ? ? ? ? ?  RŽďĂůƚ ?ƐĞŶƐŝƟǀĞďŝƉŚĂƐŝĐƵƉƚĂŬĞŽĨĐĂůĐŝƵŵ
ŝŽŶƐ ŝŶ ƉŽƚĂƐƐŝƵŵ ?ĚĞƉŽůĂƌŝǌĞĚ ƐŵŽŽƚŚ ŵƵƐĐůĞ ? ?:ŽƵƌŶĂů ŽĨ WŚĂƌŵĂĐŽůŽŐǇ ĂŶĚǆƉĞƌŝŵĞŶƚĂůdŚĞƌĂƉĞƵƟĐƐ ? ? ? ? ? Z ? ? ? ? W ? ? ? ?
>ŝƵ ?y ? ? ?zĂŶŐ ? ?y ? ?ŚĂŶŐ ?> ? ?>Ƶ ?z ? ? ?'ŽŶŐ ?D ?, ? ?dŝĂŶ ?: ?< ? ? ?  ? ? ? RŶin vivoĂŶĚin 
vitro ĂƐƐĞƐƐŵĞŶƚ ŽĨ ƚŚĞ ĂŶƟ ?ŝŶŇĂŵŵĂƚŽƌǇ ? ĂŶƟŶŽĐŝĐĞƉƟǀĞ ? ĂŶĚ
ŝŵŵƵŶŽŵŽĚƵůĂƚŽƌǇĂĐƟǀŝƟĞƐŽĨůĞŵĂƟƐƚĞƌŶŝŇŽƌĂ ?ĞǆƚƌĂĐƚ ?ƉĂƌƟĐŝƉĂƟŽŶŽĨ
ĂƵƌĂŶƟĂŵŝĚĞĂĐĞƚĂƚĞ ? ?:ŽƵƌŶĂůŽĨƚŚŶŽƉŚĂƌŵĂĐŽůŽŐǇ ? ? ? ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ?ũĞƉ ? ? ? ? ? ? ? ? ? ? ? ?
>ǇŽŶƐ ?  ? ? ? dĂǇůŽƌ ? W ?: ? ? ŚĞŶŐ ? y ?, ? ? ĂůůĂƌĚ ? ' ? ? >Ğǀŝ ?  ?^ ?   <ƌĞĚĞŶƚƐĞƌ ? : ?s ? ?  ? ? ? ? ?
 RŚĂƌĂĐƚĞƌŝǌĂƟŽŶ ŽĨ ƐƵďĞŶĚŽŵĞƚƌŝĂů ŵǇŽŵĞƚƌŝĂů ĐŽŶƚƌĂĐƟŽŶƐ ƚŚƌŽƵŐŚŽƵƚ ƚŚĞ
ŵĞŶƐƚƌƵĂů ĐǇĐůĞ ŝŶ ŶŽƌŵĂů ĨĞƌƟůĞ ǁŽŵĞŶ ? ?&ĞƌƟůŝƚǇ ĂŶĚ ^ƚĞƌŝůŝƚǇ  ? ? ?  ? ? ? W ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?^ ? ? ? ? ? ? ? ? ? ? ? ? Z ? ? ? ? ? ? ?
DĂŶĚĂů ? ? ?DŽŶĚĂů ? ?< ? ? ? ? ? ? ? R^ƚƵĚŝĞƐŽĨĂŶƟŵŝĐƌŽďŝĂůĂĐƟǀŝƟĞƐŽĨ ƐŽŵĞƐĞůĞĐƚĞĚ
ĨĞƌŶƐĂŶĚůǇĐŽƉŚǇƚĞƐŝŶĂƐƚĞƌŶ/ŶĚŝĂǁŝƚŚƐƉĞĐŝĂůĞŵƉŚĂƐŝƐŽŶĞƚŚŶŽ ?ŵĞĚŝĐŝŶĂů
ƵƐĞƐ ? ?ĨƌŝĐĂŶ:ŽƵƌŶĂůŽĨWůĂŶƚ^ĐŝĞŶĐĞ ? ? ? Z ? ? ? ? W ? ? ? ?
DĂƌƐĚĞŶ ?: ?^ ? ?^ƚƌŝĐŬůĂŶĚ ? ? ? ?ůĞŵĞŶƚƐ ?d ?> ? ? ? ? ? ? ?R'ƵĂŝĨĞŶĞƐŝŶĂƐĂƚƌĞĂƚŵĞŶƚĨŽƌ
ƉƌŝŵĂƌǇ ĚǇƐŵĞŶŽƌƌŚĞĂ ? ?dŚĞ :ŽƵƌŶĂů ŽĨ ƚŚĞ ŵĞƌŝĐĂŶ ŽĂƌĚ ŽĨ &ĂŵŝůǇ WƌĂĐƟĐĞ
 ? ? ? ? Z ?  ? ? ? W ? ? ? ? ǀŝĞǁĞĚ  ? ? :ĂŶƵĂƌǇ  ? ? ? ? ? ĨƌŽŵ ŚƩƉ P ? ?ǁǁǁ ?ŶĐďŝ ?Ŷůŵ ŶŝŚ ?ŐŽǀ ?
ƉƵďŵĞĚ ? ? ? ? ? ? ? ? ?
DďǁĂŵďŽ ?  ?, ? ? >ĞĞ ? ^ ?< ? ? DƐŚŝƵ ?  ?E ? ? WĞǌǌƵƚŽ ? : ?D ?  ? <ŝŶŐŚŽƌŶ ?  ? ? ?  ? ? ? ? ?
 RŽŶƐƟƚƵĞŶƚƐ ĨƌŽŵ ƚŚĞ ƐƚĞŵ ǁŽŽĚ ŽĨƵƉŚŽƌďŝĂ ƋƵŝŶƋƵĞĐŽƐƚĂƚĂ ǁŝƚŚ ƉŚŽƌďŽů
ĚŝďƵƚǇƌĂƚĞ ƌĞĐĞƉƚŽƌ ?ďŝŶĚŝŶŐ ŝŶŚŝďŝƚŽƌǇ ĂĐƟǀŝƚǇ ? ?:ŽƵƌŶĂů ŽĨ EĂƚƵƌĂů WƌŽĚƵĐƚƐ
 ? ? ? ? ? Z ? ? ? ? ? W ? ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ŶƉ ? ? ? ? ? ?Ğ
DĐŽŶŶĞůů ? : ?> ?  ? tĂĚǌŝŶƐŬŝ ?  ? ? ?  ? ? ? ? ?  RdĂƌŐĞƟŶŐ ƉƌŽƚĞŝŶ ƐĞƌŝŶĞ ?ƚŚƌĞŽŶŝŶĞ
ƉŚŽƐƉŚĂƚĂƐĞƐĨŽƌĚƌƵŐĚĞǀĞůŽƉŵĞŶƚ ? ?DŽůĞĐƵůĂƌWŚĂƌŵĂĐŽůŽŐǇ ? ? ? ? Z ? ? ? ? ? W ? ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ŵŽů ? ? ? ? ? ? ? ? ? ? ?
DŽŚĂŵŵĞĚďĚƵƐ^ĂƩĞƌ ?D ? ?<ŚĂŶ ?D ?D ?Z ?> ? ?:ĂďŝŶ ?^ ? ? ?ďĞĚŝŶ ?E /ƐůĂŵ ?D ?& ? ?
^ŚĂŚĂ ?  ? ?  ? ? ? ? ?  REƵƚƌŝƟŽŶĂů ƋƵĂůŝƚǇ ĂŶĚ ƐĂĨĞƚǇ ĂƐƉĞĐƚƐ ŽĨ ǁŝůĚ ǀĞŐĞƚĂďůĞƐ
ĐŽŶƐƵŵĞ ŝŶ ĂŶŐůĂĚĞƐŚ ? ?ƐŝĂŶ WĂĐŝĮĐ :ŽƵƌŶĂů ŽĨ dƌŽƉŝĐĂů ŝŽŵĞĚŝĐŝŶĞ  ? ? ? Z ?
 ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ?ĂƉũƚď ? ? ? ? ? ? ? ? ? ? ? ?
EĂƟŽŶĂůZĞƐĞĂƌĐŚŽƵŶĐŝů ? ? ? ? ? ? R'ƵŝĚĞĨŽƌƚŚĞĐĂƌĞĂŶĚƵƐĞŽĨůĂďŽƌĂƚŽƌǇĂŶŝŵĂůƐ P
ŝŐŚƚŚ ĞĚŝƟŽŶ ? ? ŝŶ /ŶƐƟƚƵƚĞ ĨŽƌ >ĂďŽƌĂƚŽƌǇ ŶŝŵĂů ZĞƐĞĂƌĐŚ ? ŽŵŵŝƩĞĞ ĨŽƌ ƚŚĞ
hƉĚĂƚĞŽĨƚŚĞ'ƵŝĚĞĨŽƌƚŚĞĂƌĞĂŶĚhƐĞŽĨ>ĂďŽƌĂƚŽƌǇŶŝŵĂůƐ ?ĞĚƐ ? Z ?'ƵŝĚĞĨŽƌƚŚĞ ĐĂƌĞ ĂŶĚ ƵƐĞ ŽĨ ůĂďŽƌĂƚŽƌǇ ĂŶŝŵĂůƐ ? Ɖ ?  ? ? ? ? EĂƟŽŶĂů ĐĂĚĞŵŝĞƐ WƌĞƐƐ ?
tĂƐŚŝŶŐƚŽŶ ? ?
EŝĞĚĞƌŐĞƌŬĞ ? Z ? ?  ? ? ? ? ?  RdŚĞ ƉŽƚĂƐƐŝƵŵ ĐŚůŽƌŝĚĞ ĐŽŶƚƌĂĐƚƵƌĞ ŽĨ ƚŚĞ ŚĞĂƌƚ ĂŶĚ ŝƚƐ
ŵŽĚŝĮĐĂƟŽŶ ďǇ ĐĂůĐŝƵŵ ? ?:ŽƵƌŶĂů ŽĨ WŚǇƐŝŽůŽŐǇ  ? ? ? ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?ũƉŚǇƐŝŽů ? ? ? ? ? ?ƐƉ ? ? ? ? ? ?
EǁŽƐƵ ? D ?K ? ?  ? ? ? ? ?  RƚŚŶŽďŽƚĂŶŝĐĂů ƐƚƵĚŝĞƐ ŽŶ ƐŽŵĞ ƉƚĞƌŝĚŽƉŚǇƚ Ɛ ŽĨ ^ŽƵƚŚĞƌŶ
EŝŐĞƌŝĂ ? ?ĐŽŶŽŵŝĐ ŽƚĂŶǇ  ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ? ? ? ? ?
 ? ? ? ? ? ? ? ? ? Z ? ? ?% ? ? ? ? ? P^K^WK% ? ? ? ? ?K ? ?
KĸĐĞ ŽĨ >ĂďŽƌĂƚŽƌǇ ŶŝŵĂů tĞůĨĂƌĞ ? E/, ?  ? ? ? ? ?WƵďůŝĐ ŚĞĂůƚŚ ƐĞƌǀŝĐĞ ƉŽůŝĐǇ ŽŶŚƵŵĂŶĞĐĂƌĞĂŶĚƵƐĞŽĨůĂďŽƌĂƚŽƌǇĂŶŝŵĂůƐ ?ǀŝĞǁĞĚ ? ?DĂƌĐŚ ? ? ? ? ?ĨƌŽŵŚƩƉ P ? ?
ŐƌĂŶƚƐ ?ŶŝŚ ?ŐŽǀ ?ŐƌĂŶƚƐ ?ŽůĂǁ ?ƌĞĨĞƌĞŶĐĞƐ ?W,^WŽůŝĐǇ>ĂďŶŝŵĂůƐ ?ƉĚĨ
KŶŽ ?z ? ?&Ƶũŝŝ ?d ? ? /ŐĂƌĂƐŚŝ ?< ? ?<ƵŶŽ ?d ? ?dĂŶĂŬĂ ? ? ?<ŝŬŬĂǁĂ ?h ?Ğƚ Ăů ? ?  ? ? ? ? ?  RWŚŽƌďŽů
ĞƐƚĞƌďŝŶĚŝŶŐƚŽƉƌŽƚĞŝŶŬŝŶĂƐĞƌĞƋƵŝƌĞƐĂĐǇƐƚĞŝŶĞ ?ƌŝĐŚǌŝŶĐ ?ĮŶŐĞƌ ?ůŝŬĞƐĞƋƵĞŶĐĞ ? ?WƌŽĐĞĞĚŝŶŐƐŽĨƚŚĞEĂƟŽŶĂůĐĂĚĞŵǇŽĨ^ĐŝĞŶĐĞƐŽĨƚŚĞhŶŝƚĞĚ^ƚĂƚĞƐŽĨŵĞƌŝĐĂ
 ? ? ? ? ? Z ? ? ? ? ? W ? ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ƉŶĂƐ ? ? ? ? ? ? ? ? ? ? ?
WĞŚůŝǀĂŶŽŒůƵ ?  ? ? ĂǇƌĂŬ ? ^ ?  ? ŽŒĂŶ ? D ? ?  ? ? ? ? ?  R ĐůŽƐĞůŽŽŬ Ăƚ ƚŚĞ ĐŽŶƚƌĂĐƟŽŶ ĂŶĚ
ƌĞůĂǆĂƟŽŶŽĨƚŚĞŵǇŽŵĞƚƌŝƵŵ ?ƚŚĞƌŽůĞŽĨĐĂůĐŝƵŵ ? ?:ŽƵƌŶĂůŽĨƚŚĞdƵƌŬŝƐŚ ?'ĞƌŵĂŶ'ǇŶĞĐŽůŽŐŝĐĂůƐƐŽĐŝĂƟŽŶ ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũƚŐŐĂ ? ? ? ? ? ? ? ? ? ? ?
WĞƌƵƐƋƵşĂ ? D ? ? ,ĞƌŶĄŶĚĞǌ ? Z ? ? :ŝŵĠŶĞǌ ? D ? ? ? WĞƌĞĚĂ ?DŝƌĂŶĚĂ ? Z   ? DĂƚĂ ? Z ? ?  ? ? ? ? ?
 RŽŶƚƌĂĐƟůĞ ƌĞƐƉŽŶƐĞ ŝŶĚƵĐĞĚ ďǇ Ă ůŝŵŽŶŽŝĚ  ?,ƵŵŝůŝŶŽůŝĚĞ  Z ŽŶ ƐƉŽŶƚĂŶĞŽƵƐ
ĂĐƟǀŝƚǇŽĨŝƐŽůĂƚĞĚƐŵŽŽƚŚŵƵƐĐůĞ ? ?WŚǇƚŽƚŚĞƌĂƉǇZĞƐĞĂƌĐŚ ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?
ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ?^// Z ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? Z ? ? P ?% ?    P P/ ?WdZ ? ? ?%   ? ? ?K ? ? ? ?
WůƵƐŬĂů ? d ? ? ĂƐƟůůŽ ? ^ ? ? sŝůůĂƌ ?ƌŝŽŶĞƐ ?  ?  ? KƌĞƐŝĐ ?D ? ?  ? ? ? ? ?  RDŵŝŶĞ  ? P DŽĚƵůĂƌ
ĨƌĂŵĞǁŽƌŬ ĨŽƌ ƉƌŽĐĞƐƐŝŶŐ ? ǀŝƐƵĂůŝǌŝŶŐ ? ĂŶĚ ĂŶĂůǇǌŝŶŐ ŵĂƐƐ ƐƉĞĐƚƌŽŵĞƚƌǇ ?ďĂƐĞĚ
ŵŽůĞĐƵůĂƌ ƉƌŽĮůĞ ĚĂƚĂ ? ?D ŝŽŝŶĨŽƌŵĂƟĐƐ  ? ? ?  ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?
 ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
^ĞŬĞŶĚĂƌ ůŝ ? D ? ? DŽƐƚĂĨĂ ? < ? ? KďĂǇĞĚ ZĂŝŚĂŶ ? D ? ? <ŚĂůŝůƵƌ ZĂŚŵĂŶ ? D ? ? ƐůĂŵ
,ŽƐƐĂŝŶ ? D ?  ? ^ŚĂŚ ůĂŵ ? D ? ?  ? ? ? ? ?  RŶƟŽǆŝĚĂŶƚ ĂŶĚ ĐǇƚŽƚŽǆŝĐ ĂĐƟǀŝƟĞƐ ŽĨ
ŵĞƚŚĂŶŽůŝĐĞǆƚƌĂĐƚŽĨƌǇŽƉƚĞƌŝƐĮůŝǆ ?ŵĂƐ ?> ? ZƐĐŚŽƩůĞĂǀĞƐ ? ?/ŶƚĞƌŶĂƟŽŶĂů:ŽƵƌŶĂůŽĨƌƵŐĞǀĞůŽƉŵĞŶƚĂŶĚZĞƐĞĂƌĐŚ ? ? ? Z ? ? ? ? W ? ? ? ?
^ŚŵŝŐŽů ? ?s ? ?ŝƐŶĞƌ ? ? ? ?tƌĂǇ ?^ ? ? ? ? ? ? ? RWƌŽƉĞƌƟĞƐŽĨǀŽůƚĂŐĞ ?ĂĐƟǀĂƚĞĚ ?Ă ?A㴃? ?ŝ Z
ƚƌĂŶƐŝĞŶƚƐŝŶƐŝŶŐůĞƐŵŽŽƚŚŵƵƐĐůĞĐĞůůƐŝƐŽůĂƚĞĚĨƌŽŵƉƌĞŐŶĂŶƚƌĂƚƵƚĞƌƵƐ ? ?:ŽƵƌŶĂůŽĨWŚǇƐŝŽůŽŐǇ ? ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?  ? ?ďŐ ?ǆ
^ŚŵŝŐŽů ? ?s ? ?ŝƐŶĞƌ ? ? ? ?tƌĂǇ ?^ ? ? ? ? ? ? ? R^ŝŵƵůƚĂŶĞŽƵƐŵĞĂƐƵƌĞŵĞŶƚƐŽĨĐŚĂŶŐĞƐ
ŝŶƐĂƌĐŽƉůĂƐŵŝĐƌĞƟĐƵůƵŵĂŶĚĐǇƚŽƐŽůŝĐ ?Ă ?A㴃?ŝŶƌĂƚƵƚĞƌŝŶĞƐŵŽŽƚŚŵƵƐĐůĞĐĞůůƐ ? ?:ŽƵƌŶĂů ŽĨ WŚǇƐŝŽůŽŐǇ  ? ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ? ? ? ? ? ? ? ? ? ? ?
 ? ? ? ? ? ? ? ? ?Ś ?ǆ
^ŚŵǇŐŽů ?  ?  ? tƌĂǇ ? ^ ? ?  ? ? ? ? ?  R&ƵŶĐƟŽŶĂů ĂƌĐŚŝƚĞĐƚƵƌĞŽĨ ƚŚĞ ^Z ĐĂůĐŝƵŵ ƐƚŽƌĞ ŝŶ
ƵƚĞƌŝŶĞ ƐŵŽŽƚŚ ŵƵƐĐůĞ ? ?Ğůů ĂůĐŝƵŵ  ? ? ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ?
ĐĞĐĂ ? ? ? ? ? ? ? ? ? ? ? ?
^ŚŽũŽ ? , ?  ? <ĂŶĞŬŽ ? z ? ?  ? ? ? ? ?  RKǆǇƚŽĐŝŶ ?ŝŶĚƵĐĞĚ ƉŚŽƐƉŚŽƌǇůĂƟŽŶ ŽĨ ŵǇŽƐŝŶ ůŝŐŚƚ
ĐŚĂŝŶŝƐŵĞĚŝĂƚĞĚďǇĞǆƚƌĂĐĞůůƵůĂƌĐĂůĐŝƵŵŝŶŇƵǆŝŶƉƌĞŐŶĂŶƚƌĂƚŵǇŽŵĞƚƌŝƵŵ ? ?:ŽƵƌŶĂů ŽĨ DŽůĞĐƵůĂƌ ZĞĐŽŐŶŝƟŽŶ  ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?
ũŵƌ ? ? ? ?
^ŚƵŬůĂ ? ^ ?  ? dŝǁĂƌŝ ? ^ ?< ? ?  ? ? ? ? ?  R/ŶƐĞĐƟĐŝĚĂů ĂĐƟǀŝƚǇ ŽĨƌǇŽƉ ĞƌŝƐ Įůŝǆ ?ŵĂƐ  ?>ŝŶŶ ? Z
ƐĐŚŽƩ ĞƚŚĂŶŽůŝĐ ĞǆƚƌĂĐƚ ĂŐĂŝŶƐƚ ŽƌĐǇƌĂ ĐĞƉŚĂůŽŶŝĐĂ ^ƚĂŝŶƚ ?  ?>ĞƉŝĚŽƉƚĞƌĂ P
WǇƌĂůŝĚĂĞ Z ? ?:ŽƵƌŶĂůŽĨŝŽƉĞƐƟĐŝĚĞ ? ? ? Z ? ? ? ? W ? ? ? ?
^ůĂƚĞƌ ? ? ?ĞŶŶĞƐ ?t ? ?^ĂǁĚǇ ?Z ? ?ůůƉŽƌƚ ?s ? ?ĞŶŶĞƩ W ? ? ? ? ? ? ? RǆƉƌĞƐƐŝŽŶŽĨĐǇĐůŽ ?
ŽǆǇŐĞŶĂƐĞ ƚǇƉĞƐ ? ? ĂŶĚ  ? ? ŝŶ ŚƵŵĂŶ ĨĞƚĂů ŵĞŵďƌĂŶĞƐ ƚŚƌŽƵŐŚŽƵƚ ƉƌĞŐŶĂŶĐǇ ? ?:ŽƵƌŶĂů ŽĨ DŽůĞĐƵůĂƌ ŶĚŽĐƌŝŶŽůŽŐǇ  ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?
ũŵĞ ? ? ? ? ? ? ? ? ? ?
^ŵŝƚŚ ? < ?D ? ? WĂŶĚĞǇ ? Z ?< ? ? ZǇĂŶ ? : ?D ? ? :ĂŐĞƌŽǀŝĐ ? E ?  ? ŽƵŐŚĞƌƚǇ  d ?: ? ?  ? ? ? ? ?ZŚŽĚŽƉŽƌƉŚǇƌŝŶ ĂŶĚ ƉŚǇůůŽĞƌǇƚŚƌŝŶ ƌĞůĂƚĞĚ ƉŚŽƚŽƐĞŶƐŝƟǌĞƌƐ ĨŽƌ ƉŚŽƚŽĚǇŶĂŵŝĐƚŚĞƌĂƉǇ ?WĂƚĞŶƚĂŶĚdƌĂĚĞŵĂƌŬKĸĐĞ ?tĂƐŚŝŶŐƚŽŶ ? ?h ?^ ?WĂƚĞŶƚEŽ ? ? ? ? ? ? ? ? ? ? ?
^ŶĞŚůĂƚĂ ?^ ? ?dŝǁĂƌŝ ?^ ?< ? ? ? ? ? ? ? RdŽǆŝĐŽůŽŐŝĐĂůĞīĞĐƚƐŽĨƌǇŽƉƚĞƌŝƐĮůŝǆ ?ŵĂƐĂŐĂŝŶƐƚ
ƚŚĞŽŶƚŽŐĞŶǇŽĨƌŝĐĞ ?ŵŽƚŚ ?ŽƌĐǇƌĂĐĞƉŚĂůŽŶŝĐĂ ?^ƚĂŝŶƚ Z ? ?tŽƌůĚƉƉůŝĞĚ^ĐŝĞŶĐĞƐ:ŽƵƌŶĂů ? ? ? ? Z ? ? ? W ? ? ?
^ŽĂƌĞ ?> ? ? ?&ĞƌĚĞƔ ?D ? ?^ƚĞĨĂŶŽǀ ?^ ? ?ĞŶŬŽǀĂ ? ? ?EŝĐŽůŽǀĂ ?Z ? ?ĞŶĞǀ ?W ?ĞƚĂů ? ? ? ? ? ? ?
 RŶƟŽǆŝĚĂŶƚ ĂĐƟǀŝƚǇ ? ƉŽůǇƉŚĞŶŽůƐ ĐŽŶƚĞŶƚ ĂŶĚ ĂŶƟŵŝĐƌŽďŝĂů ĂĐƟǀŝƚǇ ŽĨ ƐĞǀĞƌĂů
ŶĂƟǀĞ ƉƚĞƌŝĚŽƉŚǇƚĞƐ ŽĨ ZŽŵĂŶŝĂ ? ?EŽƚƵůĂĞ ŽƚĂŶŝĐĂĞ ,ŽƌƟ ŐƌŽďŽƚĂŶŝĐŝ ůƵũ ?EĂƉŽĐĂ ? ? ? ? Z ? ? ? W ? ? ?
^ŽůŽī ? D ?^ ?  ? ^ǁĞĞƚ ? W ? ?  ? ? ? ? ?  RKǆǇƚŽĐŝŶ ŝŶŚŝďŝƟŽŶ ŽĨ  ?Ă ?A㴀 DŐ ?A㴃Z ?dWĂƐĞ ĂĐƟǀŝƚǇ
ŝŶ ƌĂƚ ŵǇŽŵĞƚƌŝĂů ƉůĂƐŵĂ ŵĞŵďƌĂŶĞƐ ? ?:ŽƵƌŶĂů ŽĨ ŝŽůŽŐŝĐĂů ŚĞŵŝƐƚƌǇ  ? ? ? ?
 ? ? ? ? ? W ? ? ? ? ? ?
^ƵŬǁĂŶ ?  ? ? tƌĂǇ ? ^ ?  ? <ƵƉŝƩĂǇĂŶĂŶƚ ? ^ ? ?  ? ? ? ? ?  RdŚĞ ĞīĞĐƚƐ ŽĨ 'ŝŶƐĞŶŐ :ĂǀĂ ƌŽŽƚ
ĞǆƚƌĂĐƚŽŶƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟůŝƚǇŝŶŶŽŶƉƌĞŐŶĂŶƚƌĂƚƐ ? ?WŚǇƐŝŽůŽŐŝĐĂůZĞƉŽƌƚƐ ? ? ? ? Z ?
Ğ ? ? ? ? ? WĞ ? ? ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ?ƉŚǇ ? ? ? ? ? ? ?
dŽŐĂƐŚŝ ? < ? ?  ? ? ? ? ?  RhƚĞƌŝŶĞ ĐŽŶƚƌĂĐƟůŝƚǇ ĞǀĂůƵĂƚĞĚ ŽŶ ĐŝŶĞ ŵĂŐŶĞƟĐ ƌĞƐŽŶĂŶĐĞ
ŝŵĂŐŝŶŐ ? ?ŶŶĂůƐŽĨƚŚĞEĞǁzŽƌŬĐĂĚĞŵǇŽĨ^ ĐŝĞŶĐĞƐ ? ? ? ? ? ? Z ? ? ? W ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?ĂŶŶĂůƐ ? ? ? ? ? ? ? ? ?
dŽŐĂƐŚŝ ? < ? ? <ĂǁĂŬĂŵŝ ? ^ ? ? <ŝŵƵƌĂ ? / ? ? ƐĂƚŽ ? Z ? ? dĂŬĂŬƵƌĂ ? <  ? DŽƌŝ ? d ? Ğƚ Ăů ? ?  ? ? ? ? ?
 R^ƵƐƚĂŝŶĞĚ ƵƚĞƌŝŶĞ ĐŽŶƚƌĂĐƟŽŶƐ P  ĐĂƵƐĞ ŽĨ ŚǇƉŽŝŶƚĞŶƐĞŵǇŽŵĞƚƌŝĂů ďƵůŐŝŶŐ ? ?ZĂĚŝŽůŽŐǇ ? ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ƌĂĚŝŽůŽŐǇ ? ? ? ? ? ? ? ? ? ? ? ? ? ?
dƌŝŐŐůĞ ?  ?: ? ?  ? ? ? ? ?  RĂůĐŝƵŵ ĐŚĂŶŶĞů ůŝŐĂŶĚƐ ? ?ŶŶƵĂů ZĞǀŝĞǁ ŽĨ WŚĂƌŵĂĐŽůŽŐǇ ĂŶĚdŽǆŝĐŽůŽŐǇ ? ? ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ĂŶŶƵƌĞǀ ?ƉĂ ? ? ? ? ? ? ? ? ? ? ? ? ? ?   
hƌďĂŶ ? : ? ? <ŽŬŽƐŬĂ ? > ? ? >ĂŶŐƌŽǀĂ ? / ?  ? DĂƚĞũŬŽǀĂ ? : ? ?  ? ? ? ? RŶƚŚĞůŵŝŶƟĐ ĞīĞĐƚƐ ŽĨ
ŵĞĚŝĐŝŶĂů ƉůĂŶƚƐ ƵƐĞĚ ŝŶ ǌĞĐŚ ZĞƉƵďůŝĐ ? ?WŚĂƌŵĂĐĞƵƟĐĂů ŝŽůŽŐǇ  ? ? ? ? ? W ? ? Z ?
 ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?
tĂůƐŚ ?  ?K ?& ? ?  ? ? ? ? ?Ŷ ŝŶƚƌŽĚƵĐƟŽŶ ƚŽ ďŝŽĐŚĞŵŝƐƚƌǇ ? dŚĞ ŶŐůŝƐŚ hŶŝǀĞƌƐŝƚǇ WƌĞƐƐ ?
>ŽŶĚŽŶ ?
tĂŶŐ ?: ? ?ŽƵ ?< ? ?ŚĂŶŐ ?z ? ?>ŝƵ ? ? ?tƵ ?: ? ?ŚŽƵ ?z ?ĞƚĂů ? ? ? ? ? ? ? RŶ ? ? ?ŶŽƌƐƉŝƌŽƐƚĂŶŽů
ƐĂƉŽŶŝŶǁŝƚŚ ŝŶŚŝďŝƚŽƌǇĂĐƟŽŶĂŐĂŝŶƐƚKy ? ?ƉƌŽĚƵĐƟŽŶĨƌŽŵƚŚĞƵŶĚĞƌŐƌŽƵŶĚ
ƉĂƌƚŽĨdƌŝůůŝƵŵƚƐĐŚŽŶŽƐŬŝŝ ? ?ŚĞŵŝĐĂůĂŶĚWŚĂƌŵĂĐĞƵƟĐĂůƵůůĞƟŶ ?dŽŬǇŽ ?  ? ? ? Z ?
 ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ĐƉď ? ? ? ? ? ? ?
tŽƌůĚ ,ĞĂůƚŚ KƌŐĂŶŝǌĂƟŽŶ ? dŚĞ /ŶƚĞƌŶĂƟŽŶĂů WŚĂƌŵĂĐŽƉŽĞŝĂ ?  ? ? ?KǆǇƚŽĐŝŶ ?  ?ƚŚ
ĞĚŶ ? ?tŽƌůĚ,ĞĂůƚŚKƌŐĂŶŝǌĂƟŽŶ ?^ŝŶŐĂƉŽƌĞ ?
tƌĂǇ ? ^ ? ?  ? ? ? ? ?  RhƚĞƌŝŶĞ ĐŽŶƚƌĂĐƟŽŶ ĂŶĚ ƉŚǇƐŝŽůŽŐŝĐĂů ŵĞĐŚ ŶŝƐŵƐ ŽĨ ŵŽĚƵůĂƟŽŶ ? ?dŚĞŵĞƌŝĐĂŶ:ŽƵƌŶĂůŽĨWŚǇƐŝŽůŽŐǇ ? ? ? ? ? Z ? ? W ? ? ?
tƌĂǇ ? ^ ? ?  ? ? ? ? ?  R/ŶƐŝŐŚƚƐ ŝŶƚŽ ƚŚĞ ƵƚĞƌƵƐ ? ?ǆƉĞƌŝŵĞŶƚĂů WŚǇƐŝŽůŽŐǇ  ? ? ? ? Z ?  ? ? ? W ? ? ? ?
ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ĞǆƉƉŚǇƐŝŽů ? ? ? ? ? ? ? ? ? ? ? ?
tƌĂǇ ?^ ? ?ƌƌŽǁƐŵŝƚŚ ?^ ? ? ? ? ? ? ? RhƚĞƌŝŶĞƐŵŽŽƚŚŵƵƐĐůĞ ? ?&ƵŶĚĂŵĞŶƚĂůŝŽůŽŐǇĂŶĚDĞĐŚĂŶŝƐŵƐŝƐĞĂƐĞ ? ? ? ? ? ? W ? ? ? ? ?
tƌĂǇ ?^ ? ?:ŽŶĞƐ ?< ? ?<ƵƉŝƩĂǇĂŶĂŶƚ ?^ ? ?>ŝ ?z ? ?DĂƩŚĞǁ ?  ?DŽŶŝƌ ?ŝƐŚƚǇ ? ?ĞƚĂů ? ? ? ? ? ? ?
 RĂůĐŝƵŵƐŝŐŶĂůŝŶŐĂŶĚƵƚĞƌŝŶĞĐŽŶƚƌĂĐƟůŝƚǇ ? ?:ŽƵƌŶĂůŽĨƚŚĞ^ŽĐŝĞƚǇĨŽƌ'ǇŶĞĐŽůŽŐŝĐ/ŶǀĞƐƟŐĂƟŽŶ ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?^ ? ? ? ? ? ? ? ? ? ? ?Z   ? ? ? ? ?
tƌĂǇ  ^ ? ? <ƵƉŝƩĂǇĂŶĂŶƚ ? ^ ? ? ^ŚŵǇŐŽů ?  ? ? ^ŵŝƚŚ ? Z ? ?  ?ƵƌĚǇŐĂ d ? ?  ? ? ? ? ?  RdŚĞ
ƉŚǇƐŝŽůŽŐŝĐĂů ďĂƐŝƐ ŽĨ ƵƚĞƌŝŶĞ ĐŽŶƚƌĂĐƟůŝƚǇ P  ƐŚŽƌƚ ƌĞǀŝĞǁ ? ?ǆƉĞƌŝŵĞŶƚĂůWŚǇƐŝŽůŽŐǇ ? ? ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ĞƉŚ ? ? ? ? ? ? ?
tƵ ?W ?> ? ?>ŝŶ ?& ?t ? ?tƵ ?d ?^ ? ?<ƵŽŚ ? ?^ ? ?>ĞĞ ?< ?, ? ?>ĞĞ ^ ?: ? ? ? ?  ? ? RǇƚŽƚŽǆŝĐĂŶĚĂŶƟ ?
,/s ƉƌŝŶĐŝƉůĞƐ ĨƌŽŵ ƚŚĞ ƌŚŝǌŽŵĞƐ ŽĨ ĞŐŽŶŝĂ ŶĂŶƚŽĞŶƐŝƐ ? ?ŚĞŵŝĐĂů ĂŶĚWŚĂƌŵĂĐĞƵƟĐĂůƵůůĞƟŶ ? ? ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ĐƉď ? ? ? ? ? ? ?
tƌĂǇ ?^ ? ?EŽďůĞ ?< ? ? ? ? ? ? ? R^ĞǆŚŽƌŵŽŶĞƐĂŶĚĞǆĐŝƚĂƟŽŶ ?ĐŽŶƚƌĂĐƟŽŶĐŽƵƉůŝŶŐŝŶƚŚĞ
ƵƚĞƌƵƐ P dŚĞ ĞīĞĐƚƐ ŽĨ ŽĞƐƚƌŽƵƐ ĂŶĚ ŚŽƌŵŽŶĞƐ ? ?:ŽƵƌŶĂů ŽĨ EĞƵƌŽĞŶĚŽĐƌŝŶŽůŽŐǇ
 ? ? ? ? Z ? ? ? ? W ? ? ? ?ŚƩƉƐ P ? ?ĚŽŝ ?ŽƌŐ ? ? ? ? ? ? ? ? ?ũ ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?ǆ
tƵ ?d ?^ ? ?>ŝŶ ?z ?D ? ?,ĂƌƵŶĂ ?D ? ?WĂŶ ? ?: ? ?^ŚŝŶŐƵ ?d ? ?ŚĞŶ ?z ?W ?Ğƚ Ăů ? ? ? ? ? ? ? RŶƟƚƵŵŽƌ
ĂŐĞŶƚƐ ? ? ? ? ?<ĂŶƐƵŝƉŚŽƌŝŶƐĂŶĚ ?ƚǁŽŶŽǀĞůĂŶƟůĞƵŬĞŵŝĐĚŝƚĞƌƉĞŶĞĞƐƚĞƌƐĨƌŽŵƵƉŚŽƌďŝĂ ŬĂŶƐƵŝ ? ?:ŽƵƌŶĂů ŽĨ EĂƚƵƌĂů WƌŽĚƵĐƚƐ  ? ? ? ? Z ?  ? ? ? W ? ? ? ? ŚƩƉƐ P ? ?ĚŽŝ ?
ŽƌŐ ? ? ? ? ? ? ? ? ?ŶƉ ? ? ? ? ?Ă ? ? ?
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